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Within the general literature on infections and suicidal behavior, studies on Toxoplasma
gondii (T. gondii) occupy a central position. This is related to the parasite’s neurotropism,
high prevalence of chronic infection, as well as specific and non-specific behavioral
alterations in rodents that lead to increased risk taking, which are recapitulated in
humans by T. gondii’s associations with suicidal behavior, as well as trait impulsivity
and aggression, mental illness and traffic accidents. This paper is a detailed review of
the associations between T. gondii serology and suicidal behavior, a field of study that
started 15 years ago with our publication of associations between T. gondii IgG serology
and suicidal behavior in persons with mood disorders. This “legacy” article presents,
chronologically, our primary studies in individuals with mood disorders and schizophrenia
in Germany, recent attempters in Sweden, and in a large cohort of mothers in Denmark.
Then, it reviews findings from all three meta-analyses published to date, confirming our
reported associations and overall consistent in effect size [ranging between 39 and
57% elevation of odds of suicide attempt in T. gondii immunoglobulin (IgG) positives].
Finally, the article introduces certain links between T. gondii and biomarkers previously
associated with suicidal behavior (kynurenines, phenylalanine/tyrosine), intermediate
phenotypes of suicidal behavior (impulsivity, aggression) and state-dependent suicide risk
factors (hopelessness/dysphoria, sleep impairment). In sum, an abundance of evidence
supports a positive link between suicide attempts (but not suicidal ideation) and T.
gondii IgG (but not IgM) seropositivity and serointensity. Trait impulsivity and aggression,
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endophenotypes of suicidal behavior have also been positively associated with T. gondii
seropositivity in both the psychiatrically healthy as well as in patients with Intermittent
Explosive Disorder. Yet, causality has not been demonstrated. Thus, randomized
interventional studies are necessary to advance causal inferences and, if causality is
confirmed, to provide hope that an etiological treatment for a distinct subgroup of
individuals at an increased risk for suicide could emerge.
Keywords: Toxoplasma gondii, suicide, suicidal behavior, suicide attempts, self-directed violence, impulsivity,
aggression

INTRODUCTION

chemical and physical environment, and brain and behavior.
With multiple national and international collaborators, we had
the privilege to contribute with several first-of-their-kind reports.
In the neuroimmune domain, we were: (1) the first to identify
altered cytokine gene expression (postmortem) in regions of
the prefrontal cortex that are implicated in suicidal behavior
(21), although in a subsequent work with a different diagnostic
composition containing many descendants with substance abuse,
we failed to replicate the original findings (22); (2) the first
to report an association of immune triggers in spring [such as
influenza B and coronaviruses (23) and seasonal pollen peaks]
with suicidal behavior (24, 25) that was later replicated by two
independent groups (26, 27); and, (3) the first to model the
effect of pollen on prefrontal cortex cytokine gene expression,
exacerbation of anxiety-like behavior and impairment in social
interactions in animal models (28). We were also the first, in
collaboration, to report an association between blood kynurenine
levels, the initial step of the tryptophan degradation pathway,
and a history of suicide attempt in individuals with mood
disorders (29). The Postolache group’s work on allergens
led to identifying, for the first time, mood worsening when
individuals with sensitivity to specific aeroallergens [identified
by plasma allergen-specific immunoglobulin G (IgG)] were
exposed to those specific aeroallergens (30). We also used
animal models and found that rodents exhibited aggressivelike behaviors (intermediate phenotypes of suicidal behavior)
after a combined stress-allergic challenge [sensitization and
exposure to allergens and acute behavioral stress (forced
swim test)] (31). Furthermore, Postolache’s group reported,
pharmacoecologically, lower suicide rates associated with the use
of intranasal corticosteroids (medications able to substantially
reduce mediators of inflammation in the nasal cavity), relative to
new-generation antihistamines (32), which are symptomatically
equally effective, but not as effective as intranasal corticosteroids
in reducing the local production and potential cerebral
translocation of mediators of inflammation. Comorbidity with
asthma and its treatment (33), exacerbation of mood disorders
(34, 35), or new onset or exacerbation of sleep problems (36)
appeared as plausible mediators of emotional and behavioral
dysregulation in allergic rhinitis. Furthermore, the nasal-cortical
pathway could act as a superhighway (bypassing the bloodbrain barrier) for chemical and cellular mediators from the
nasal cavity to reach the brain (37). In all, Postolache team’s
findings strongly suggest that a biological (rather than purely
psychological) mediation is in operation, and is responsible
for the predictive association between allergic rhinitis and

Suicidal Behavior
Annually, 0.8 million individuals worldwide die by suicide (1).
Moreover, every death by suicide is accompanied by 10–20
suicide attempts, leading to an annual number of global suicide
attempters of ∼10 million (2). Suicidal behavior (including fatal
and non-fatal suicidal self-directed violence) is a multi-factorially
determined phenomenon (3, 4) in which predispositions and
triggers, protective and aggravating factors, availability of means,
social and professional supports, as well as deterrents, all interact
in a reciprocal interplay that determines short- and long-term
risk and prognosis. Interventions geared toward increasing
social support, safety (by reducing access to lethal means;
e.g., firearm), protective obstacles, hotlines, and education of
the public have been recommended as universal (5–7) and
selective (3, 6, 8) interventions. Additionally, several explanatory
models have been proposed that have usefulness, both in
theoretically understanding suicidal behavior among cohorts,
and in providing an organized manner by which to characterize
specific and dynamic risk factors in individual patients. The
models include: (1) the stress-diathesis model (9–12), and; (2) the
interpersonal model of suicidal behavior introduced by Joiner,
which emphasizes the need for a temporal coexistence of a wish
to die (as a result of “thwarted belongingness” and “perceived
burdensomeness”) and a capability to engage in suicidal behavior
(resulting from habituation to pain and death/dying, often due
to repeated exposures to fear-inducing or physically threatening
or painful experiences) (13). Several biological factors underlying
either vulnerability or triggering of suicide have been proposed
and have been summarized and integrated (14). Biological
factors that are supported by data include genetic, epigenetic
(including microRNAs), endocrine (most commonly implicated
are glucocorticoids, gonadal steroids), and neuroimmune factors,
sleep and circadian domains (15), neurotransmitters, and brain
regions (such as the frontal cortical regions that mediate
inhibitory control/impulsivity) (10–12, 16–19). While many of
these biomarkers, moderators, or mediators have been previously
related directly to suicidal behavior, they are also strongly related
to endophenotypes of suicidal behaviors (see Figure 1) (12, 20).

Contributions to the Field of
Neuroimmunology of Suicide Before
Toxoplasma gondii
Dr. Postolache’s group at the University of Maryland School of
Medicine has been studying interactions between the biological,
Frontiers in Psychiatry | www.frontiersin.org
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FIGURE 1 | Intermediate phenotypes for suicidal behavior. Model displaying candidate genes, endophenotypes, and environmental risk factors implicated in suicidal
behavior that may lend themselves to further study in animal model systems. The upper portion shows the cumulative liability for suicide originating in the dynamic
(Continued)
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FIGURE 1 | interplay between environmental, genetic, and epigenetic factors. Attempted suicide is a major risk factor but does not always predate suicide as
suggested in the figure. Gene loci, genes, candidate endophenotypes and links among these factors remain to be discovered. Many psychosocial stressors are not
listed in the figure because of the biological focus. Specific gene loci and genes were not included because of the current limitations in knowledge, and the absence of
adequate replication at the time of publication. TBI, traumatic brain injury. T. gondii finds its place on the right upper side under “Harmful” environmental factors
(Allergens/Pathogens) [Reprinted with permission from (20); Copyright (2020); License link: http://creativecommons.org/licenses/by/4.0/].

Animal Studies Premising T.
gondii-Suicidal Behavior Connection

suicidal behavior, and between aeroallergen exposure and
suicidal behavior. The team has also published the negative
results of its initial failure to replicate (38) its original report
(24) of non-violent suicide associations with pollen counts in
the United States, and its successful replication in Denmark
(25). The convergence of the results of the Postolache team’s
animal, clinical, and postmortem studies, led to a retreat
contemplating and discussing the biological relevance of the
uncovered associations, where the idea of including latent
infection with Toxoplasma gondii (T. gondii) in our research
portfolio originated (see paragraph A Summary of the Postolache
Group’s Studies on T. gondii, Suicidal Behavior, and Suicide Risk
Factors/Intermediate Phenotypes).

Rodents with chronic (“latent” —i.e., almost undetectable with
the naked eye) T. gondii infection exhibit significantly altered
behavior with associated abnormal neuroendocrine structure
and function. The effects of infection can be classified as nonspecific (such as increased exploration, enhancing predation by
any predator, and thus, leading to formation of cysts in the brain
and muscle of these predators) and specific (relating to reduced
aversion or even attraction toward cats, the permanent hosts of
T. gondii). Examples of non-specific effects are lessening of an
aversion for open/ less protected spaces and increased noveltyseeking in rodents (41–45). More striking is the reversal of the
innate aversion to feline odors in rodents, which allows them
to avoid their most common predator (any representative of
the cat family), leading to a “fatal attraction” (46–50), is an
illustration in mammals of the common behavioral manipulation
of the host by the parasite among submammalian organisms.
In rodents, the loss of the aversion of predator odors is specific
for cats, and not present for other predators that do not play
a role of permanent hosts for T. gondii. Moreover, this loss of
aversion to cat odors is probably an evolutionary phenomenon
that increases the parasite’s capacity to reproduce, as the ingested
meat of infected rodents delivers T. gondii to the feline intestinal
system, where it undergoes sexual differentiation and sexual
reproduction (47, 51).

The Postolache Team’s Research on
Toxoplasma gondii, Suicidal Behavior, and
Its Intermediate Phenotypes—A Summary
T. gondii is an intracellular protozoan parasite that most often
results in an asymptomatic or oligosymptomatic infection in
approximately one-third of humans worldwide. A relatively
lower prevalence (10–15%) has been reported in the United States
(US) (39), although a high prevalence has been reported in
certain farming communities, such as the Old Order Amish
(40). T. gondii is zoonotic and can infect any warm-blooded
animal. Depending on the degree of immunocompetence of the
host and the mechanism of infection, the severity of symptoms
can be minimal (in most cases), or severe in (rare cases).
If a mother has a primary infection during pregnancy and
transmits the infection to her fetus, a potentially devastating
congenital infection occurs, with long-term consequences to
the offspring. In terms of transmission, felids have been
recognized as the definitive hosts of T. gondii. The parasite
multiplies sexually in the gut of any representative of the
felid species, which spreads the oocysts. The ingestion of
the parasite within the oocysts by humans and any warmblooded animal, which play a role of “intermediate hosts,”
leads to the spread of the microorganism as tachyzoites
(fast-growing forms) from the intestine to other organs,
predominantly the muscles and the brain, where it forms
cysts containing slow-growing forms (bradyzoites). Further
ingestion of these cysts results in closing of the loop of T.
gondii reproduction cycle in cats, and a secondary spread from
the intestine to muscle/brain, with a secondary formation of
bradyzoites. In conditions of reduced immune pressure on
the parasite, bradyzoites transform into tachyzoites that invade
locally, and via circulating immune cells, distally into the
host’s organs.

Frontiers in Psychiatry | www.frontiersin.org

Associations Between T. gondii and Mental
Health
Chronic infection with T. gondii has been associated with
behavioral, cognitive, psychotic, and affective aberrations in
humans (52). Psychiatric disorders, including bipolar disorder
(53–57) and schizophrenia (54, 58–65), have been reported to be
linked with chronic T. gondii infection. Moreover, depression has
been reported to be associated with chronic T. gondii infection
in multiple cohorts, such as pregnant women (66), individuals
with mental illness (67) and female Veterans (34). However,
the association between T. gondii infection and depression
has not been replicated in other research studies (53, 68–71).
Heterogeneity in the studied samples may have contributed
to this discrepancy. Potential risk factors for heterogeneity in
the study participants include infection with different T. gondii
strains, co-morbid substance use disorders, lifestyle variations,
different mechanisms of T. gondii infection (tissue cyst vs.
oocyst), differential associations of individual symptoms of
depression with T. gondii infection, or variations in genetic
vulnerability of the individuals to depression linked with T.
gondii infection.
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A Summary of the Postolache Group’s
Studies on T. gondii, Suicidal Behavior, and
Suicide Risk Factors/Intermediate
Phenotypes

with certain methodological differences and they included studies
that were not completely overlapping, their conclusions are
highly convergent and consistent with respect to the direction
of the findings and their magnitude, when compared with
the Postolache group’s initial articles in patients with mood
disorders, schizophrenia, acute attempters, and the Danish
cohort of mothers.

Our very simplistic initial thinking was that, if pollen or other
aeroallergens are misperceived as invasive pathogens (most
likely as parasites because of Th2 cytokine involvement and
eosinophil count elevations) and trigger a robust immune
defense mechanism that affects brain and behavior, in a sizeable
proportion of the population, it is also likely that there are
candidate parasites that invade humans with a similar rate as
aeroallergens, but do not by themselves cause more harm than the
consideration of several alternatives, T. gondii seemed, by far, the
most likely candidate. T. gondii is a small, intracellular parasite,
with seropositivity rates (72) that were similar to airborne allergy
(73). It is distinctly neurotropic and had already been implicated
in mental illness. Being fortunate to have collaborators with
the needed expertise, and available samples and data, we first,
successfully identified positive associations between T. gondiispecific IgG serointensity and history of suicide attempt in
individuals with mood disorders (74). This was the first study
connecting T. gondii and suicidal behavior; up until then the only
articles in PubMed connecting suicide with T. gondii were on
apoptosis (i.e., “suicidal death of cells”). A study in Turkey was
the second to find an association between T. gondii and suicidal
behavior, this time with both IgG serointensity and seropositivity
(75). Subsequently, the Postolache group’s intent was to test
the uncovered association across diagnostic boundaries, as this
appeared to be the simplest confirmation that the relationship
between T. gondii and suicidal behavior is primary, rather
than secondary to exacerbation of mental illness. We followed
with a positive association between T. gondii IgG serointensity
and suicidal behavior in younger persons with schizophrenia
in Germany (N = 1,000) (76), and with a history of suicide
attempt in individuals admitted for suicide attempts vs. healthy
controls in Sweden, including the scores on a suicide rating
scale used to evaluate risk of suicidal behavior in Sweden (77).
We then proceeded with a first longitudinal, large, retrospective
cohort analysis in Danish mothers, confirming associations
between self-directed violence or violent suicide attempts and
T. gondii IgG seropositivity and stratified titers obtained from
neonatal blood spots from neonates. This was the first study in
which measurement of T. gondii markers occurred prior to the
phenotypic behavioral observation and remains the largest study
to date (78).

Sutterland et al. 2019
The systematic review guidelines from the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA)
statement (79) were applied in this meta-analysis (80) that
combined 14 studies on suicide attempt/suicide. A systematic
search was done throughout EMBASE, Medline, and PsychInfo
till February 11, 2019 (Prospero #CRD42018090206). Inclusion
criteria were: (i) original scientific studies in any language; (ii)
having comparable quantitative data; (iii) analyses of latent T.
gondii infection via any of the following assays that measure
IgG antibodies: enzyme-linked immunosorbent assay (ELISA)
or immune fluorescence, Sabin–Feldman dye test, immune
hemagglutination, or complement fixation; (iv) cohort or case–
control studies with human subjects; and (v) data on suicide
attempts. Exclusion criteria were: (i) no control group; (ii) case
series or case reports; and (iii) inclusion of immunocompromised
individuals. Three researchers performed screening of search
results by examining abstracts and manuscript titles. The
Cochrane criteria of quality for cohort or case–control studies
(81) were followed to screen study quality, independently by
two researchers. The type of controls (healthy controls vs.
psychiatric controls) without suicide attempt history were criteria
for stratification of analyses. Studies were classified as having a
prospective design when measurement of Toxoplasma antibodies
preceded the behavioral outcome in a longitudinal cohort, or
when, in a cross-sectional study, the antibody measurement
followed shortly after the suicide attempt. Another grouping was
based on studies that included only schizophrenia patients vs.
studies that included other diagnostic categories.
For seropositivity definition, the reported criteria in each
study were used, and if multiple methods were reported, the ones
that used the smallest effect size were analyzed. Serointensity
(antibody titers) were also analyzed as either reported by
individual studies or deduced from average antibody titers
reported in the study.
An odds ratio (OR) was computed for all studies, with
utilization of ORs adjusted for confounders, when accessible.
All analyses used random effect modeling. Eyeballing and
calculating I2 were used to estimate heterogeneity among studies.
Comprehensive Meta-analysis Software 3.0 (82) was used for
meta-analytical calculations. For better estimation of the true
ORs, when applicable, Duval and Tweedie’s trim and fill method
was used. Egger’s test (significant if the one-sided p < 0.10) and
examination of funnel plots were used to estimate the potential
for bias. The latent T. gondii global prevalence (Pglob) was
estimated to be 30% (83), and the population attributable fraction
(PAF) was calculated using the formula: PAF = [Pglob × (RR
– 1)]/[Pglob × (RR – 1) + 1] (84), where RR is the Risk Ratio
(at low frequencies identical to Odds Ratio) (85). To estimate

META-ANALYTIC CONFIRMATION AND
REPLICATION OF THE POSTOLACHE
GROUP’S FIRST REPORTED
ASSOCIATION BETWEEN T. GONDII
SEROLOGY AND SUICIDAL BEHAVIOR
We are going to present the three meta-analyses that are
currently available. Primary articles included are listed in
Table 1. Although these three meta-analyses were performed

Frontiers in Psychiatry | www.frontiersin.org
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References/Study

Included in
Sutterland/
Amouei/
Soleymani
Metaanalysis

Arling et al. (74)
Yes/Yes/Yes
[First study reporting
that suicide attempters
had greater mean T.
gondii IgG titers than
non-suicide attempters
(p = 0.004)]

Country

Study
design

USA

Analysis
method

Test

Age (Year ± SD)/
(minimum,
maximum)

Sex (N)

Case-control EIA (S)

IgG

P: NA
C: NA

P: (F:47, M:34) Yes
C: (F:NA, M:NA)

Case
population

Results: OR (95% CI) Other
relevant findings (n, % in
cases and controls,
respectively)a

Mood
disorders and
healthy

Mood
disorders

1.26 (0.56–2.83)
Seropositivity: OR 1.62 (95%
CI 0.72–3.65) Geometric Mean
IgG values (±S.D.), adjusted for
age, gender and race: 0.51
(±0.46) v. 0.37 (±0.50)

Psychiatric
disorders

1.79 (1.18–2.71)
Seropositivity: 82/200 (41%) v.
56/200 (28%) Matched on age,
gender, SES, urbanicity and
dietary habits

T. gondii Control
population
serointensity
reported

Yes/Yes/Yes

Turkey

Case-control ELISA

IgG
IgM

P: (24.31 ± 7.57)
C: (24.34 ± 8.01)

P: (F:159, M:41) No
C: (F:155, M:45)

Healthy

Okusaga et al. (23)

Yes/Yes/Yes

Germany

Crosssectional

EIA (S)

IgG

P: (38.6 ± 11.1)
C: (37.6 ± 11.9)

P:
(F:137, M:214)
C:
(F:213, M:386)

Yes

Schizophrenia Schizophrenia 1.18 (0.90–1.54)
Seropositivity, adjusted for
gender, education, PANSS,
duration of illness and plate:
Adjusted OR (<38 years): 1.57
(1.03–2.38) Adjusted OR (>38
years): 0.79 (0.53–1.19)
Serointensity:
Adjusted OR (<38 years):
1.23 (1.04–1.47) Adjusted OR
(>38 years): 0.90 (0.76–1.01)

Pedersen et al. (78)
[Largest sample size
and first prospective
study]

Yes/Yes/Yes

Denmark

Cohort

EIA

IgG

P: (15, 61)
C: (15, 61)

P: (F:1,005) C:
(F:44,783)

Yes

Self-directed
violence
(mothers
giving birth to
first child)

6

Yagmur et al. (75)

Self-directed
violence
(mothers
giving birth to
first child)

(Continued)
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1.28 (1.12–1.47)
Seropositivity: SDV: 168/488
(34%) v. 11,949/44,783 (26%)
Serointensity: SDV: IgG levels
split into 6 categories with rising
adjusted RR (adjusted for age,
follow-up time, psychiatric
contact and history): 0–24
(seronegative) taken as
reference, with 25–45 showing
RR of 1.08 (95% CI 0.70–1.58)
and eventually >84 showing RR
of 1.91 (95% CI 1.25–2.79)

Postolache et al.

Frontiers in Psychiatry | www.frontiersin.org

TABLE 1 | Individual studies used in the three meta-analyses with suicide attempts as the outcome measure presented in the article.

References/Study

Included in
Sutterland/
Amouei/
Soleymani
Metaanalysis

Country

Study
design

Analysis
method

Test

Age (Year ± SD)/
(minimum,
maximum)

Sex (N)

T. gondii Control
seropopulation
intensity
reported

Case
population

Results: OR (95% CI) Other
relevant findings (n, % in
cases and controls,
respectively)a

Zhang et al. (77)

Yes/Yes/No

Sweden

Crosssectional

ELISA

IgG

P: (38.4 ± 14.4)
C: (39.8 ± 14.2)

P: (F:31, M:23)
C: (F:19, M:11)

Yes

Healthy

Psychiatric
disorders

2.75 (0.97–7.83)
Seropositivity: 22/54 (41%) v.
6/30 (20%) Age-adjusted
log-transformed mean IgG
titers (±S.D.): 3.0 (±0.1) v.
2.6 (±0.2)

Alvarado-Esquivel et al. Yes/Yes/Yes
(86)

Mexico

Case-control EIA

IgG
IgM

P: (34.01 ± 10.25)
C: (38.26 ± 11.62)

P: (F:119, M:37) Yes
C: (F:76, M:51)

Psychiatric
disorders

Psychiatric
disorders

0.55 (0.20–1.49)
Seropositivity: 7/156 (5%) v.
10/127 (8%) High antibody titers
(>150 IU/ml): 7/7 (100%) v.
5/10 (50%)

Samojłowicz et al. (87)

Poland

Case-control IFA

IgG

P: (20, 89)
C: (18, 81)

P: (F:5, M:36)
C: (F:7, M:79)

No

People who
People who
died suddenly died suddenly
due to disease due to suicide

1.65 (0.77–3.55)
Seropositivity: 26/41 (63%) v.
41/83 (49%)

Mexico

Case-control EIA

IgG
IgM

(36.01 ± 12.48)

(F:123, M:26)

Yes

Psychiatric
disorders

0.27 (0.06–1.26) Seropositive:
2/57 (3.5%) v. 13/92 (14.1%)
Serointensity: The frequency of
high (>150 IU/ml) anti-T. gondii
IgG levels was lower (but not
statistically significant) in patients
with suicide attempt (2/57, 3.5%)
than in those (11/92, 12%)
without suicide attempt (p
= 0.13).

Yes/Yes/Yes

Alvarado-Esquivel et al. No/Yes/No
(88)

Psychiatric
disorders

7
Yes/Yes/Yes

France

Crosssectional

ELISA (S)

IgG
IgM

P: (48.1 ± 12.0)
C: (42.3 ± 13.7)

P: (F:29, M:25)
C: (F:47, M:51)

Yes

2.00 (0.86–4.63)
Bipolar
Bipolar
disorder type I disorder type I Seropositive: 45/54 (83%) v.
69/97 (71%) Serointensity (mean
and II
and II
titer ±S.D.): 3.30 (±1.47) v.
2.84 (±1.69)

Fond et al. (89)

Yes/Yes/Yes

France

Crosssectional

ELISA (S)

IgG
IgM

P: (36.2 ± 11.4)
C: (35.4 ± 11.5)

P: (F:13, M:30)
C: (F:18, M:53)

Yes

Schizophrenia
or
schizoaffective
disorder

Schizophrenia
or
schizoaffective
disorder

Coccaro et al. (117)

No/Yes/No

USA

Crosssectional

ELISA (S)

IgG

P: (36.1 ± 8.3)
C: (31.3 ± 8.7)

P: (F:45, M:64)
C: (F:52, M:58)

No

Different states
(healthy,
psychiatric and
Intermittent
Explosive
Disorder)

Different states 1.42 (0.59–3.44)
(healthy,
psychiatric and
Intermittent
Explosive
Disorder)

1.42 (0.63–3.18)
Seropositive: 30/43 (70%) v.
44/61 (72%) Serointensity (mean
titer ±S.D.): 2.68 (±1.69) v.
2.53 (±1.81)

(Continued)
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References/Study

Included in
Sutterland/
Amouei/
Soleymani
Metaanalysis

Country

Study
design

Analysis
method

Test

Age (Year ± SD)/
(minimum,
maximum)

Sex (N)

T. gondii Control
seropopulation
intensity
reported

Case
population

Results: OR (95% CI) Other
relevant findings (n, % in
cases and controls,
respectively)a

Coryell et al. (90)

Yes/Yes/Yes

USA

Case-control ELISA

IgG

P: (17.5 ± 1.7)
C: (19.0 ± 1.6)

P: (F:13, M:4)
C: (F:65, M:26)

No

Adolescents
with mood
disorders

Adolescents
with mood
disorders

5.93 (0.78–45.40)
Seropositivity: 2/17 (12%) v.
2/91 (2%) Mean IgG titers
(±S.D.): Adjusted for age
and gender

Sugden et al. (91)

Yes/Yes/Yes

New Zealand Cohort

IgG

P: (38)
C: (38)

(F:414, M:423)

No

Psychiatric
disorders

Psychiatric
disorders

2.60 (0.96–7.01)
Seropositivity: Suicide attempt
since age 32: 8/236 (3.4%) v.
8/601 (1.3%)

Ansari-Lari et al. (92)

Yes/Yes/Yes

Iran

Case-control ELISA

IgG

P: (43.5 ± 8.1)
C: (38.0 ± 11.1)

P: (F:10, M:32)
C: (F:17, M:40)

Yes

Schizophrenia Schizophrenia 1.03 (0.42–2.51)
Seropositivity: 8/42 (19%) v.
21/57 (37%) Mean IgG
titers (±S.D.): 7.7 (±11.7) v.
12.5 (±13.7)

Samojłowicz et al. (104) No/Yes/No

Poland

Case-control ELISA

IgG

P: (18, 89)
C: (20, 89)

P: (F:13, M:113) No
C: (F:25, M:140)

Individuals
who died as a
result of
disease

Individuals
who died as a
result of the
risky behavior

1.66 (1.04–2.66)

Bak et al. (93)

South Korea Case-control CLIA

IgG

P: (18, 80)
C: (22, 59)

P: (F:69, M:66)
C: (F:80, M:75)

Yes

Healthy

Depressive
symptoms

2.49 (1.06–5.82)
Seropositivity: 21/155 (14%) v.
8/135 (6%) High antibody titers
(>150 IU/ml): 7/21 (33%) v.
2/8 (25%)

No

Schizophrenia Schizophrenia 1.27 (0.26–6.25)

EIA

8
Yes/Yes/Yes

No/Yes/Yes

France

Cohort

IgG

(32.0 ± 8.6)

(F:66, M:184)

Yes/Yes/No

Denmark

Case-control ELISA (S)

IgG

P: (37.4)
C: NA

No
P:
(F:377, M:278)
C: (F:NA, M:NA)

Blood donors
(psychiatric
disorders
without
registered
suicide
attempt)

Blood donors
(psychiatric
disorders with
registered
suicide
attempt)

1.25 (1.04–1.49)
Seropositivity: 193/655 (29%) v.
1,633/6,503 (25%) Prospective
subgroup; outcome after
blood sampling: 3/23 (13%) v.
1,319/5,259 (25%)

Sari and Kara (102)

No/Yes/No

Turkey

Case-control ELISA

IgG
IgM

P: (12, 17)
C: (12, 18)

P: (F:43, M:7) C: No
(F:43, M:7)

Healthy

Psychiatric
disorders

7.44 (0.37–147.92)

Yalin Sapmaz et al.
(103)

No/Yes/No

Turkey

Crosssectional

IgG
IgM

(15.6 ± 1.59)

(F:31, M:6)

Depression

Depression

94.50 (7.45–1198.62)

EIA (S)

ELISA

No

C, control; CI, confidence interval; CLIA, chemiluminescent immunoassay; EIA, enzyme immunoassay (S): solid-phase EIA; ELISA, enzyme-linked immunosorbent assay (S): solid-phase ELISA; F, female; IF, indirect immunofluorescence;
IgG, immunoglobulin G; IgM, immunoglobulin M; IU, International unit; M, male; mL, milliliter; OR, odds ratio; P, patient; PANSS, Positive and Negative Syndrome Scale; S.D., standard deviation; SDV, self-directed violence; SES,
socioeconomic status; v., versus.
a Data of cases are presented first, control population second.
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group’s individual study, only the schizophrenia patients that
were younger (23) or those with the plasma tryptophan’s
metabolite kynurenine in the highest quartile (95) manifested
an association between T. gondii and suicide attempts. It is
possible that the link between T. gondii and schizophrenia is
stronger (54) than its association with suicidal behavior and that
the initial elevation in suicide risk in response to the diagnosis
and early losses associated with the illness is a much more
impactful clinical phenomenon. It may also be possible that
other aspects outweigh the potential suicide risk elevation by
T. gondii infection in schizophrenia patients. For instance, in
schizophrenia patients, T. gondii serology interactive biomarkers
(such as monoamine metabolites) are also associated with
other independent suicide risk factors, including autoimmune
markers [such as gliadin antibodies (96)], or smoking (97),
that may override in magnitude the strength of T. gondii
associations. In regard to psychiatric vs. healthy controls, the
lack of significance when psychiatric controls were used suggests
several possibilities—it is possible that despite impressions at an
individual study level (where the associations have been robust
to adjustment for psychiatric illness), some degree of mediation
via mental illness, or perhaps confounding by severity of mental
illness cannot be ruled out. Nevertheless, in our collaborative
study (78), the associations between T. gondii and subsequent
suicide attempts were robust with adjustment for baseline mental
illness (and even parental history of mental illness). Additional
T. gondii-related variables, such as strain and the method of
infection (at present it is possible to test for an oocyst targeting
IgG antibody) require further research.
The calculated PAF is epidemiologically and clinically
meaningful, with 1 in 10 suicide attempts being averted if T.
gondii infection is completely prevented or chemically eradicated.
Identifying the characteristics of specific T. gondii positive
individuals with recurrent suicide attempts who may benefit the
most from interventions geared to prevent reactivation is an
important aim of a future preliminary study.

the degree by which the moderators altered variance of the
main effect, the moderators were analyzed as covariates using
regression analysis with methods of moments for continuous
variables and mixed-effects analysis for categorical variables. For
each specific moderator R2 was calculated.

Results
An overall significant OR (for suicide attempt) of 1.39 [95%
confidence interval (CI): 1.10–1.76, p = 0006] (see Figure 2)
was associated with T. gondii infection (seropositivity) in the
thirteen published studies, that evaluated the association between
suicide attempt/death by suicide and latent T. gondii infection
and one study that was not published (74–78, 86, 87, 89–94). The
Egger’s test did not identify bias (p = 0.15). Additionally, similar
and significant OR was rendered by Duval and Tweedie’s trim
and fill analysis. Considerable heterogeneity among studies was
identified (I 2 = 55%, p = 0.003, τ 2 = 0.103). Two main sources of
heterogeneity have been identified—the diagnostic composition
of the samples (schizophrenia only vs. other diagnoses) and the
nature of controls (psychiatric vs. normal controls). In samples
consisting of individuals with a diagnosis of only schizophrenia,
no significant elevation in OR for suicide attempt was observed in
T. gondii-positive cases, but in samples of individuals with mixed
psychiatric disorders, the association was significant [OR = 1.8
(95% CI: 1.44–2.24), p < 0.001]. In turn, when psychiatric (nonattempter) controls were used, the association was not significant,
while when healthy controls were used, the association was
robust and significant [OR = 1.9 (95% CI: 1.48–2.44), p < 0.001].
In regard to serointensity, only eight studies were identified,
starting with Postolache group’s first study—(74, 76–78, 86, 89,
92, 93), rendering an overall OR of 1.22 (95% CI: 0.96–1.55, p
= 0.11), with no significant results in schizophrenia [OR = 0.99
(95% CI: 0.77–1.29)] but significant in mixed diagnostic samples
[OR = 1.66 (95% CI: 1.29–2.12, p < 0.001]. A high heterogeneity
among studies was identified (I 2 = 62%, p = 0.004, τ = 0.252).
When investigating potential sources of heterogeneity, a robust
and significant diagnostic effect emerged (R2 = 61%, p = 0.004)
with no significant associations in studies on participants with
schizophrenia [OR = 0.99 (95% CI: 0.77–1.29)] vs. various other
psychiatric disorders [OR = 1.66 (95% CI: 1.29–2.12), p < 0.001].
Population attributable fraction: If the average infection rate
of T. gondii in humans globally is assumed to be 30%, the
computed PAF [0.3 × (OR – 1)]/[0.3 × (OR – 1) + 1], showed
that in theory if T. gondii infection can be totally prevented,
suicidal behavior would decrease by ∼10% (95% CI: 3–19%).

Soleymani et al. 2020
This systematic review and meta-analysis (98) followed the
PRISMA guidelines (79) and presents combined results of 15
studies. The authors searched Institute for Scientific Information
(ISI), Medline, and Scopus, and the reference list of selected
studies for case-control, cohort, and cross-sectional studies that
investigated associations between suicidal behavior (as outcome)
and T. gondii infection (as predictor). Egger and Begg tests were
used to evaluate publication bias. I 2 statistics and chi-square tests
were used to assess heterogeneity among studies. For combining
results, a random effect approach was used.

Relevance
This is the first meta-analysis confirming an association between
suicide attempts and T. gondii serology, as we had originally
reported. The association of T. gondii serointensity with suicide
attempts in samples that did not include schizophrenia patients
exclusively, confirmed the very first link between T. gondii
serology and suicide attempts that the Postolache group and
their collaborators had identified in patients with recurrent mood
disorders (74). Regarding the uncovered effect of psychiatric
diagnosis, with insignificant associations between T. gondii
serology and suicide attempts in schizophrenia in the Postolache
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Results
Odds of suicidal behavior were higher in T. gondii seropositive
vs. seronegative individuals [OR = 1.43 (95% CI: 1.15–1.78)]
(see Figure 3). No publication bias was identified (Egger and
Begg test: p = 0.28). The I 2 test demonstrated a moderate
heterogeneity (I 2 = 0.71) leading to the choice of random-effect
modeling to perform the meta-analysis.
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FIGURE 2 | Forest plot showing an association between T. gondii infection and suicide attempts as reported in a meta-analysis by Sutterland et al. (80) using the
random effects model. Serointensity has not been presented, and, thus, the first study on T. gondii infection and suicide attempt appears as negative [Modified and
reprinted with permission from (80); Copyright (2019); with permission from Cambridge University Press; License # 4963421068137].

“PubMed,” “ScienceDirect,” “Scopus,” “Web of Science,”
“PROSPERORegister,” “EMBASE,” “CINAHL,” and “ProQuest”
were searched, without language restriction. Five studies on
suicidal ideation and 22 studies on suicide attempts were
combined. In addition to the added focus on suicidal ideation,
this meta-analysis also analyzed T. gondii immunoglobulin M
(IgM), and not only IgG.
The quality of selected studies was checked with the
standard checklist of the Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) (106).
Statistical heterogeneity among studies was evaluated using
Cochran’s Q test (represented as chi-square and p-values)
and index I 2 representing percentage of variability due
to heterogeneity (107). The study planned to use random
effects modeling if the heterogeneity was significant or high
(p < 0.05 or I 2 > 50%). The analysis used random effects
models. A meta-regression analysis was used for separately
evaluating the contribution to heterogeneity of moderators
represented by differences in sub-groups based on the type
of study, target population, control population, detection
method, and continent. For univariate meta-regression and

Relevance
The Soleymani et al. (98) meta-analysis analyzed several studies
[for example (99–101)] not included in Sutterland et al. (80) and
Amouei et al. (105) meta-analyses, but also left out several studies
that were included in those meta-analyses [e.g., (77, 94, 102–
104)]. It errs in naming suicide attempts as suicides, and it
phrases the conclusion in a causal way. Additionally, parasuicides
were also included in the “suicide” category, leading to a broader
inclusion of self-directed violence—i.e., suicidal and nonsuicidal, lethal and non-lethal. Nevertheless, despite its unprecise
definition of outcome and only partially overlapping study
selection, the study still confirmed the significant association
with T. gondii, and yielded an effect size similar to the previous
meta-analysis of Sutterland et al. (80).

Amouei et al. 2020
This meta-analysis (105) evaluated the potential association
of T. gondii with the risk of suicidal ideation and suicide
attempts. PRISMA guidelines (79) were followed and the
protocol was enlisted with The International Prospective
Register of Systematic Reviews (PROSPERO). “Google Scholar,”

Frontiers in Psychiatry | www.frontiersin.org
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FIGURE 3 | Results (odds ratios and 95% confidence intervals) from the individual studies and the meta-analysis by Soleymani et al. (98). The first study from the
Postolache group, by Timothy Arling is wrongly identified as Timothy et al. instead of Arling et al. (74). Furthermore, studies that have identified associations between
serointensity (but not seropositivity), such as Arling et al. (74) and Okusaga et al. (95) appear as carrying no significant association [Modified and reprinted with
permission from (98); Copyright (2020); with permission from Springer Nature; License link: http://creativecommons.org/licenses/by/4.0/].

multivariable meta-analysis, R2 values were calculated to
express the effects of moderators as covariates (specifically
the amount of heterogeneity in the meta-regression and
meta-analysis that can be explained by the moderator
variables). Funnel plots were used to illustrate the risks of
bias and the Egger’s regression test was used to evaluate
the presence of bias (positive for p < 0.10) (108). For a
better estimation of true OR, when applicable, the Duval
& Tweedie non-parametric “fill and trim” linear random
method was used. To estimate the possibility that one
single study is responsible for the meta-analytic results,
a sensitivity analysis using the “omitting one” method
was implemented.

was a significant association with T. gondii IgG seropositivity
[OR = 1.57 (95% CI: 1.23–2.00)] (see Figure 4), but not with
IgM seropositivity [OR = 1.41 (95% CI: 0.78–2.54)]. There was
no evidence of publication bias (Egger test; p = 0.25). The
“leave-one-out” sensitivity analyses confirmed the robustness of
the findings. A high level of heterogeneity was noted (χ 2 =
68.72, p = 0.000, I 2 = 70.9%). A univariable meta-regression to
identify the source of heterogeneity failed to identify a univariate
significant moderation. Specifically, the location/continent, the
study design (β = 0.31, p = 0.31, R2 = 9.90), the control
population (β = −0.52, p = 0.07, R2 = 8.19), the method
of diagnosis (β = 0.34, p = 0.18, R2 = 17.35), or the target
population (β = −0.22, p = 0.39, R2 = 20.30) exerted no
significant effect on the heterogeneity among studies. However,
when the combined effect of these variables was analyzed,
interactively, the continents (β = 0.66, p = 0.04), the study
design (β = 0.84, p = 0.01) and type of control group
(β = −2.84, p = 0.03) had a significant effect on suicide
risk. When all moderators were entered simultaneously in the
multiple regression model as covariates of the true effect, they
explained 34.7% of the variance (τ 2 = 0.48, R2 = 0.347) of the
main effect.

Results
Suicidal ideation was not significantly associated with T. gondii
IgG seropositivity [OR = 0.90 (95% CI: 0.42–1.94)] based on
a random effects application. The Egger’s test suggested no
significant bias (p = 0.86), the Duval and Tweedie’s trim and
fill model provided the same ORs, and the “leave one out”
sensitivity analysis showed that no single study substantially
influenced the negative result. For suicide attempts, there
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FIGURE 4 | Forest plot showing a correlation between T. gondii infection (IgG) and suicide attempts as reported in a meta-analysis from 21 data sets by Amouei et al.
(105). Serointensity associations with suicide attempts, even when significant, such as Arling et al., Okusaga et al., and Zhang et al. are not presented and studies
thus appear as carrying no significant association with T. gondii serology [Modified and reprinted with permission from (105); Copyright (2020); with permission from
John Wiley & Sons; License # 4963420399853].

gondii IgG seropositivity and suicide attempt was stronger than
in previous meta-analyses [OR = 1.57 (95% CI: 1.23–2.00)].

Relevance
The relevance of this third meta-analysis is that it is larger
than previous meta-analyses and it also included suicide ideation
studies rather than only suicide attempts, and T. gondii IgM
rather than IgG positivity studies only. There was no significant
association between suicide ideation and T. gondii IgG (five
studies) and IgM (three studies) positivity. Even if in the
primary papers, a strong association between IgM positivity and
suicidal behavior was reported (OR = 2.41) (100), no significant
meta-analytic association between IgM positivity and suicide
attempt emerged. The relevance of IgM relies on the current
understanding, a departure from the past, that it may reflect not
only an acute infection, but also infection with a new serotype
or reactivation of the parasite (109). The association between T.

Frontiers in Psychiatry | www.frontiersin.org

Summary of Meta-Analyses
The three recent meta-analyses converge in supporting a
moderate association between T. gondii IgG seropositivity and
suicide attempt. In sum, the odds of suicide attempt are between
39 and 57% higher in T. gondii-IgG positive individuals. The
three studies used similar methods with all using the PRISMA
guidelines. All studies used random effects modeling. Quality was
determined by different methods—Sutterland et al. (80) used the
Cochrane criteria of quality on case–control or cohort studies
(81), Amouei et al. (105) used Strengthening the Reporting of
Observational Studies in Epidemiology checklist (STROBE) to
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FIGURE 5 | Trait Impulsivity (SSS-V Disinhibition) by Age, Sex, and T. gondii IgG Status (N = 949). Among younger men aged 20–59 years old, T. gondii seropositivity
was significantly associated with higher impulsive sensation-seeking (SSS-V Disinhibition) (p < 0.01). The two age groups are separated by median age (60 years). T.
gondii IgG (–), T. gondii IgG seronegative, T. gondii IgG+, T. gondii IgG seropositive, SSV = Sensation Seeking Scale-V [Reprinted with permission from (114);
Copyright (2015); with permission from Elsevier; License # 4964160181012].

countries (113). In addition to the specific dominant serotype,
dominant way of infection (oocyst vs. tissue cyst), exposure to
gut, respiratory, indoor and outdoor flora, especially during
critical time intervals during early childhood, may lead to longterm contributory, neutral or even protective outcomes from T.
gondii infection. For instance, asthma was negatively correlated
with T. gondii prevalence in European countries (low statistical
trend) and positively correlated in non-European countries.
Similarly, suicide had positive low-grade associations in
European countries and negative associations in non-European
ones. This could not be explained as differential association of
T. gondii with violence in general, as violence was positively
associated with suicidal behavior across the continents (113).
As an informed working hypothesis for future studies, nonpsychotic patients compared to a healthy control group, using a
prospective study design (antibodies measured first, or if second,
after a very brief interval after attempt), and a higher lethality
attempt will more likely yield a stronger effect size of T. gondii
associations with suicide attempts. This information may be of
significant interest for future randomized clinical trials.

assess the quality of selected studies (106), and Soleymani et al.
(98) used the Newcastle and Ottawa statement (NOS) checklist
(110). Sutterland et al. (80) and Amouei et al. (105) share the use
of Egger test and visual inspection, while Soleymani et al. (98)
reported the Begg test (111). I 2 was used by all studies to estimate
heterogeneity among studies. There were also unique features:
Sutterland et al. (80) analyzed serointensity and Amouei et al.
(105) analyzed suicidal ideation and not only attempt, T. gondii
IgM antibodies and not only IgG antibodies, and was the only
one to perform an omitting one sensitivity analysis.
Limitations include the lack of information on the
socioeconomic status among groups, potentially as a
confounding variable contributing to both infection and
suicidal behavior, and limited information on IgG avidity,
immune activation and T. gondii serotypes. The diagnosis
of patients (schizophrenia vs. others), the nature of control
participants (healthy vs. psychiatric), the location of the study,
and study design (e.g., cross-sectional vs. longitudinal) may have
contributed to heterogeneity of findings among the different
meta-analyses. Major differences exist between continents
and countries in regard to the prevalence of Toxoplasmosis
(112), likely contributing to heterogeneity (113). Additionally,
many medical conditions (“disease burden”) had disabilityadjusted life years (DALY) or mortality correlate with T. gondii
seroprevalence in an ecological approach with minimum
adjustment (for GDP only), and thus, tentatively representing
potential “hidden variables” for the T. gondii–suicide association.
However, many conditions associated with T. gondii infection
manifested opposite correlations in European vs. non-European
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SEARCHING FOR POTENTIAL
MECHANISMS OF THE UNCOVERED
ASSOCIATION, EVEN BEFORE
ESTABLISHING CAUSALITY
After identifying significant links between T. gondii seropositivity
and suicidal behavior in patients with mood disorder,
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immediate rewards while discounting future consequences
(“delayed discounting”) (145). Finally, work by Jung et al.
which demonstrates widespread yet discrete changes in both
functional brain networks and interconnectivity, corroborates
previous findings regarding cognitive dysfunction among those
at increased risk for death by suicide (146).
The rodent versions of the Iowa Gambling Task exhibit
good construct and face validity (147, 148). This task in rats is
modulated by the serotonin transporter level, as shown before in
humans (149). Furthermore, in a rat chronic pain model (150),
Iowa Gambling Task impairment was associated with a reduction
in 5-hydroxyindoleacetic acid in the orbitofrontal cortex.
In rodents, latent T. gondii infection reverses innate fear of cat
odor, and other stimuli that precede predation (49). The reduced
fear and anxiety-like behavior reported in infected rodents may
be the result of dendritic retraction in the basolateral amygdala,
lower corticosterone secretion (151), and epigenetic modulation
in the medial amygdala (152). Evidence suggests alterations
in decision-making in rats infected with T. gondii, specifically
induction of effort aversion by the parasite (153).
Although there is literature on latent Toxoplasmosis and
impulsivity in healthy humans (114) and individuals with
Intermittent Explosive Disorder (117), there is no report, to
our knowledge, on decision-making deficits. We have just
completed a 5 year study on Veterans, with Iowa Gambling
Task measurements in suicide attempters and controls, with and
without IgG markers of T. gondii infection. Results are pending.
If they are able to confirm that impaired decision-making, a
known risk for suicidal behavior, is linked to chronic infection
with T. gondii, and possibly that decision-making impairments
mediate or moderate the T. gondii-induced elevation of risk
of suicidal behavior, then impaired decision-making could
potentially become an endophenotypic marker of suicide-risk
associated with T. gondii infection.

schizophrenia, acute attempters, and mothers (post-delivery),
we then went on to analyze intermediate phenotypes of suicidal
behavior rather than suicide attempts. We reported, for the
first time, age- and gender-specific associations between trait
impulsivity and aggression and T. gondii status in 1,000 superhealthy individuals with no personal and parent family history of
mental illness or suicidal behavior (limiting the collision between
personality traits, genetic and early developmental influences
on mental illness, and psychiatric treatment) (114). Further,
we analyzed interactions between T. gondii serology and the
plasma monoamine precursor for serotonin and kynurenine (i.e.,
tryptophan) in predicting suicidal behavior in schizophrenia
patients. We found that coexistence of a high plasma kynurenine
(top quartile) and positive T. gondii IgG serology were necessary
for a significant link between T. gondii and history of suicidal
behavior in persons with a diagnosis of schizophrenia (95).
In the endophenotypic direction (impulsivity, aggression),
elevated levels of plasma phenylalanine/tyrosine (Phe:Tyr) ratios
(specifically in the top quartile)—precursors of catecholamines
including dopamine—interacted significantly with T. gondii
seropositivity in younger males only in predicting impulsivity
(115). Additionally, T. gondii seropositivity moderated the
association between Phe:Tyr ratio and aggression (i.e., only
in the T. gondii seropositive group—an association between a
higher ratio between Phe:Tyr and aggression was significant)
(116). The associations between T. gondii seropositivity and
both impulsivity and aggression (self-report and observed) were
further confirmed in a psychiatric population with high levels of
explosive impulsive aggression, i.e., individuals with Intermittent
Explosive Disorder (117).

Clinical Syndromes Potentially Connecting
T. gondii With Suicidal Behavior
Various cognitive and neuropsychological abnormalities, as
well as executive function deficits, are associated with suicidal
behavior (118–125). A number of studies have identified links
between T. gondii and progressive cognitive deficits in humans
(126–131), although there are also negative reports (132). In
addition to the general low-grade immune activation by T. gondii
and priming of immune cellular substrates in the brain that
may represent the most common underlying mechanism, there
is also a more novel hypothesis based on pathogen-mediated Nmethyl-D-aspartate (NMDA) receptor autoimmunity and barrier
dysfunction (133).

Sleep and Wake Abnormalities
Considering that sleep abnormalities are more readily correctable
risk factors for suicidal behavior (15), and that sleep is
dysregulated by dopamine and NMDA receptor stimulation
(increased in chronic T. gondii infection), as well as by low-grade
immune activation (present in Toxoplasmosis), and because
sleep deprivation alters decision-making and elevates suicide risk,
we hypothesized that sleep abnormalities mediate the association
between latent infection with T. gondii and suicidal behavior. If
so, we expected that sleep abnormalities would be abundantly
identified in T. gondii IgG positives in a relatively large number
(N = 833) of participants with high seroprevalence of T. gondii,
such as Old Order Amish. This would have then provided a
potential targetable behavioral aim to reduce suicide risk in T.
gondii-infected individuals, via treating their sleep abnormalities.
However, our results were disappointing, with no significant
detrimental association of sleep problems with T. gondii serology.
In fact, T. gondii-seropositive Amish individuals reported less
sleep problems and daytime problems due to poor sleep, and
longer, rather than shorter sleep duration, with earlier mid-sleep
time and bedtime (154). It is possible, just as with allergies, that
certain strains or mode of infection (e.g., tissue cyst vs. oocyst)
of T. gondii in specific undetermined conditions and for certain

Decision-Making Deficits and Suicidal
Behavior
Data suggest that, for some, suicidal behavior is linked to
deficits in cognitive functioning that negatively impacts planning,
regulation of goal directed behavior, and strategic decisionmaking (134, 135). For example, work by Jollant et al. showed
that those with a history of violent suicide attempts demonstrated
deficits on the Iowa Gambling test, a test of decision-making
in an emotionally charged context (136, 137). Deficits of
decision-making represent both a state and especially trait (and
endophenotype) markers in suicidal behavior (138–144). These
findings are supported by results suggesting that those with a
history of suicide attempts perform in a manner that prioritizes
Frontiers in Psychiatry | www.frontiersin.org
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and fear modulation, such as the prefrontal cortex (49, 193,
194). Particularly, chronic infection with T. gondii potentially
contributes to the reduced fear and anxiety-like behavior by
inducing dendritic retraction in the basolateral amygdala (151).
Two genes coding for tyrosine hydroxylase (rate-limiting enzyme
involved in dopamine synthesis) (195) are present in the T. gondii
genome. It has been reported that when stimulated, PC12 cells
infected with T. gondii release greater levels of dopamine (48).
Neurotoxicity and increased arousal are potential consequences
of dopamine increase, further contributing to increased risk of
suicidal self-directed violence (SSDV). Throughout the lifetime
of immunocompetent individuals, T. gondii continues to live
in a slow-growing form called bradyzoite. Yet, intermittent
reactivations occur in states of relative immunosuppression,
which has been specifically proposed to be one mechanism by
which psychiatric episodic manifestations and exacerbations, as
well as episodes of self-directed violence, could occur during
immunosuppression (196, 197).
An important mechanism of resistance for the host is the
relative tryptophan deprivation of the microorganism through
degradation of tryptophan toward kynurenines, mediated by
activation of the enzyme indoleamine 2,3-dioxygenase (IDO)
by pro-inflammatory cytokines (157). Activation of IDO
also elevates production of kynurenine pathway metabolites,
quinolinic acid (QUIN) and kynurenic acid (198), known
to be potent neuromodulators (199) of NMDA receptors.
Mice with chronic T. gondii infection have a 7-fold increase
in brain kynurenic acid content and a smaller increase in
kynurenine levels, implying an activation of kynurenine pathway
enzymes (200).
Kynurenine findings may be highly relevant for the
associations between infection and suicidal behavior and
between inflammation and suicidal behavior. The collaborative
work of our group at the University of Maryland with Dr.
Mann’s group at Columbia University led to the first report
of elevated plasma kynurenine levels in individuals with a
diagnosis of major depression, with vs. without history of
suicide attempts (29). Particularly, cerebrospinal fluid (CSF)
kynurenic acid concentrations were found to be associated
with increased IL-6 levels and violent suicide attempts (201).
In Postolache team’s collaborative study with Lena Brundin’s
group at the University of Lund, CSF QUIN levels were found
to be elevated in individuals with recent non-fatal suicidal
self-directed violence (NF-SSDV) (in particular, those with
more severe SSDV), independent of psychiatric diagnosis, with
normalization of these values 6 months after a suicide attempt
that had led to a hospitalization (202). Consistently, increased
postmortem counts of QUIN-reactive microglial cells in suicide
victims was found in the anterior midcingulate cortex (MCC)
and subgenual anterior cingulate cortex (sgACC) of suicides
(203). QUIN is an excitotoxic NMDA receptor agonist, and
potentially, its elevation in individuals with T. gondii infection
may represent, in the future, a more targeted application of
ketamine that shows a robust anti-suicidal effect within minutes
or hours after intravenous administration (204, 205).
Elevation of titers of T. gondii IgG may reflect a more
recent infection, more virulent infection, or a more extensive

phenotypes, serves as a microbial “Old Friend” —modulating
immune responses, and thus, reducing downstream effects of
chronic low-grade immune activation.
In a study on Old Order Amish, the Postolache group
reported an association between trait hopelessness and T.
gondii IgG serointensity (155) (which could reflect a more
widespread infection, or a more reactivating or neurotropic
course (see section Hopelessness and T. gondii Serointensity in
Old Order Amish).
In conclusion, while the decision-making deficits, other
cognitive abnormalities, and trait hopelessness could mediate
T. gondii predictive links with suicidal behavior, this requires
confirmation in targeted experiments. Additionally, it is
highly unlikely that sleep disturbances mediate the predictive
association between T. gondii and suicidal behavior.

Potential Molecular Mechanisms Linking T.
gondii With Suicidal Behavior
Immune dysregulation is a major candidate mediator of the
association between T. gondii and suicidal behavior. A low-grade
immune activation is necessary to contain the parasite to its
slow-growing form inside tissue cysts, with pro-inflammatory
cytokines playing a central role (156, 157), through activation
of microglia and monocyte-derived macrophages trafficking
to the central nervous system (CNS) (158) and activation of
lymphocytes and macrophages in the periphery (159). Moreover,
the intermittent immune escape and reactivation of T. gondii
results in an immune response to tachyzoite formation, and local
and systemic invasion leading to more pronounced elevations in
molecular mediators of immune activation. For instance, higher
peripheral levels of tumor necrosis factor (TNF) and interleukin
6 (IL-6) in suicide attempters relative to healthy controls and
non-suicidal depressed patients have been previously reported
(160). Similarly, there have been reports of T. gondii-seropositive
individuals having elevated levels of IL-6 (161); TNF has an active
role in controlling T gondii replication (162), and was reported
to be elevated in T. gondii-positive women (66) and in suicide
attempters (160).
Findings relating immune activation with T. gondii and
suicidal behavior would need to account for mental illness,
either through design (comparison groups, inclusion/ exclusion)
or through adjustments, as more literature emerges regarding
inflammation and mental illness, including major depressive
disorder (163–165), bipolar disorder (163, 166, 167), and
schizophrenia (163, 168–171), as well as treatment of mental
illness (172–175). In both animal studies (176–179) as well as
human literature (180–184), behavioral dysregulation commonly
observed among those with mental illness, such as trait
impulsivity (185, 186) and aggression (187–190) that are
described as intermediate phenotypes for suicidal behavior (12,
191, 192), have been also positively associated with higher levels
of inflammation.
To reduce exposure to mediators of the immune system,
the parasite hides within cystic structures inside glial cells and
neurons. Cysts containing T. gondii primarily concentrate in
brain regions involved in fear induction, such as the amygdala,
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Statistical methods included analysis of variance and logistic
and linear regressions. Greater T. gondii antibody titers were
found in suicide attempters than in non-suicide attempters (p
= 0.004). No other hypothesis-driven or exploratory analyses
yielded any significant result.
Inclusion criteria for patient groups was to meet DSM-IV
criteria for Major Depressive Disorder or Bipolar I or II Disorder,
and for controls was not to meet any criteria for axis I disorder
(213). Suicide attempt history was obtained with The Columbia
Suicide History Form (214).
Stored plasma samples were tested for IgG antibodies to
T. gondii by solid phase enzyme immunoassay (as described
previously) (215). Antibody levels were analyzed quantitatively
(serointensity) and qualitatively (intensity of anti-T. gondii
antibodies >10 international units). The laboratory technician
was blind to diagnosis or caseness.

infestation. A more recent reactivation or more frequencies
of activation may also be possible explanations. Furthermore,
molecular mimicry may lead to a direct effect of the IgG
antibodies. IgG antibodies against T. gondii, as well as other
infectious agents, may cross-react with epitopes in neural tissue
(206, 207). This remains speculative, as it has not been studied
specifically for T. gondii.
Effects of T. gondii infection on the homeostatic interactions
between the gut microbiota and gastrointestinal mucosa may
provide an alternative pathway for T. gondii elevating the risk
of suicide. Acute T. gondii infection induces gastrointestinal
inflammation that is dependent on CD4+ T lymphocytes located
in the lamina propria, mediated by pro-inflammatory cytokines
and by subepithelial bacterial translocation (208) and increased
gut permeability. Infection with T. gondii, despite its transient
passage through the gut during acute infection, has longterm effects on mucosal immunity, resulting in activation of
microbiota-specific T cells and loss of tolerance to gut commensal
bacteria (209). It has been suggested that intestinal inflammation
induced by T. gondii bears a resemblance to inflammatory bowel
disease (IBD), especially Crohn’s disease (210), and conversely,
anti-T. gondii antibodies are increased in individuals with IBD
(211). Moreover, IBD is a well-known risk factor for suicide (212).
We will now revisit in more detail several of the Postolache
team’s studies on T. gondii, specifically: (1) the first study in
mood disorder; (2) the first prospective study; (3) the study in
schizophrenia in which we intersected T. gondii with plasma
kynurenine levels; (4) the study in healthy individuals relating
intermediate phenotypes for suicidal behavior to T. gondii; and
(5) the intersection of Phe:Tyr ratio and T. gondii seropositivity
in relationship to impulsivity.

Results
Using logistic regression, we found a significant association
between serointensity level and suicide attempt [OR = 1.55
(1.14–2.12), p = 0.006]. The association of seropositivity with
suicide attempt was not significant [OR = 1.62 (0.72–3.65)].
No association between any marker of T. gondii and number of
suicide attempts was significant. There were no differences in
T. gondii antibody levels between those with Major Depressive
Disorder vs. Bipolar Disorder (p = 0.55), with vs. without a mood
disorder (p = 0.22), or with vs. without psychotic symptoms
(p = 0.34).

Implications
This was the very first study connecting T. gondii and suicidal
behavior. Limitations of this first study were that the information
about suicide attempt predated, in some individuals, by a long
time, the blood draw (a limitation shared by many future studies),
and that the sample size did not allow for quantitative analyses
and we could not adjust for socio-economic risk factors—
important confounders. Because T. gondii seropositivity was not
associated with a history of suicide attempt (due likely to smaller
statistical power as a categorical vs. continuous variable), our
report, while given the precedence over others in meta-analysis,
has been reported as a negative study, as meta-analyses have
generally not analyzed the serointensity (98, 105). While it is
not known what specifically generates higher titers in specific
individuals, the extent of cyst infection (mainly in the brain and
muscle), the frequency and recency of reactivation, and a higher
virulence of the infection are candidate factors. Certain patterns
in results will be repeated in the future—the association with
suicidal behavior appeared not to be mediated by associations
with mental illness and reported number of suicide attempts did
not relate significantly to T. gondii serology.

THE FIRST REPORT: T. GONDII SEROLOGY
IN INDIVIDUALS WITH MOOD DISORDERS
The Postolache team and their collaborators from Johns Hopkins
University and Sheppard Pratt were the first to test the specific
hypothesis of an association between T. gondii IgG (serointensity
and seropositivity) and suicidal behavior (74). We specifically
hypothesized that T. gondii serology is positively associated
with having attempted suicide in the past and with number
of attempts, the strongest predictor of suicide. We tested our
hypotheses using samples obtained from ongoing studies on
potential environmental triggers of depression exacerbation and
suicide attempts in individuals with recurrent mood disorders.
T. gondii serology was compared between suicide attempters
(all with history of mood disorders: 99 participants) with two
control groups—psychiatric control (history of mood disorders
without history of suicide attempt; 119 participants) and a
healthy control group (39 individuals). A Structured Clinical
Interview for DSM IV was the basis for establishing diagnosis.
This was an analysis of existing clinical and behavioral data, and
analysis of blood samples collected from two other studies—one
from a study on potential environmental triggers of depression
exacerbation and allergens, and one from a study on suicide
attempts in individuals with recurrent mood disorders.
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The great majority of studies have usually related T. gondii
seropositivity or serointensity to a psychiatric phenotype that had
an onset prior to the results of the blood draw for the antibody
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test for T. gondii, confirming an infection with the parasite. It
is thus possible that the presence of the psychiatric phenotype
may have contributed to T. gondii infection. Indeed, decreases
in self-care in mood and psychotic disorders, cognitive deficits,
and the general impulsivity that accompanies presentations of
a number of psychiatric syndromes may result in decreases in
hand hygiene, washing of fruits and vegetables, cooking time of
meat products, and the general decrease in socio-economic status
may lead to general contamination with oocysts. For instance,
some studies have attempted to relate new onset schizophrenia
to T. gondii, in that way avoiding the long-term exposure to
positive and negative symptoms and effects of medications.
Nevertheless, having the blood test occur after the diagnosis
maintains a good possibility of a “reverse causality,” i.e., that
mental illness causes a greater risk for infection. Thus, having the
T. gondii blood test performed before a psychiatric diagnosis in
a large cohort may overcome the issue of reverse causality and
provide data to support the hypothesis that T. gondii infection is
causing the psychiatric phenotype, rather than the opposite. In
this vein, a previous Danish cohort study on mothers showed
that a high level of T. gondii IgG antibodies determined in
neonatal blood spots was associated with significantly elevated
risk of schizophrenia spectrum disorders (216). The same cohort
study was used for a study on suicidal behavior, a collaborative
effort between the Danish register research in Aarhus, Denmark
(217, 218) (PI Mortensen) and University of Maryland School of
Medicine (PI Postolache). This collaborative effort was initially
supported by the National Institutes of Health for a project on
allergens, allergy, and suicidal behavior, using data in Danish
registers (NIMH R01- PI Postolache) (25, 78). We briefly present
the study here.

population. The mother-offspring T. gondii antibody titers were
highly correlated (Spearman correlation = 0.76; p < 0.001).
ICD 8 and 10 codes for SSDV and suicide attempts were
used, as described in Pedersen et al. (78). We used the date
of death from suicide or the date of the first contact for selfdirected violence (whichever came first) as the time of onset of
self-directed violence. Excluding poisoning and “unspecified” as
method, we also analyzed violent suicide attempts.
The Cox proportional hazards models (Cox regression) (222,
223) were used to estimate incidence rate ratios of self-directed
violence, which were stated as relative risks. A comparison of
estimated log minus-log survival curves was used to evaluate the
proportional hazards assumption.
Adjustments included age at delivery, and, secondarily, history
of self-directed violence (including suicide) in the parents of
the mothers, time since first psychiatric contact, and psychiatric
history. Mental illness history in parents and in women
were treated as time-dependent variables. Analysis followed a
categorical dichotomous model (seropositive and seronegative)
and a ranked model with seropositive IgG levels divided into
groups according to the 25th, 50th, 75th, and 90th percentiles. We
also stratified, secondarily, for history of mental illness (present
or not present). The likelihood ratio tests (222) were used to
calculate p-values and 95% confidence intervals. The Danish Data
Protection Agency approved the study.

Results
Seropositivity, based on the bimodal distribution of IgG levels,
was defined as an IgG level > 24, yielding a seropositivity
rate at the time of delivery of 26.80% (95% CI, 26.33–27.28).
As compared to T. gondii–seronegative mothers, seropositive
mothers had a 1.53-fold (95% CI, 1.27–1.85; p < 0.001) significant
relative risk of self-directed violence. When subdividing the
seropositive values according to the 25th, 50th, 75th, and 90th
percentiles, the risk of self-directed violence increased with the
category based on T. gondii IgG levels. As such, women with
an IgG level > 83 had a relative risk of 1.91 (95% CI, 1.25–
2.79) relative to seronegative women. In violent attempts, the T.
gondii effect was stronger—i.e., relative risk of a violent suicide
attempt in seropositive women was 1.81 (95% CI, 1.13–2.84; p
= 0.01), when compared with seronegative women. The sample
size was not sufficient to analyze death by suicide as, in the
cohort of 45,788 women, only 18 died by suicide during 604,844
person-years at risk. Yet, even if not significant given the small
effect-size, the effect size seemed stronger for suicide as compared
with SSDV or violent suicide attempt [2.05 (95% CI, 0.78–5.20; p
= 0.14)].

Methods
A neonatal screening for T. gondii (219) was the original aim
of the cohort study involving pregnant women residing in 5
Denmark counties from 1992 to 1995 (representing 1/3 of the
county). These women were given a choice to have their neonate
screened for T. gondii antibodies shortly after delivery. The
study included only the first delivery, if the mother gave birth
several times during the study. Accurate linkage between national
registers was enabled by a personal identification number listed in
the Danish Civil Registration System (218).
In the grandparent study (219), 5 to 10 days after birth, a
heel stick blood sample was obtained and stored on filter paper.
Analysis of two 3.2-mm discs was done by enzyme immunoassay
for T. gondii IgG antibodies (220). The level of antibodies was
represented by the percentage of the optical density obtained
from the World Health Organization international standard
serum and the IgG level was calculated by obtaining the mean of
the two results. An IgG level > 24 in a neonate was considered T.
gondii-seropositive in the mother at the time of delivery. Because
newborn children infected with the parasite do not produce
T. gondii–specific IgG until about the age of 3 months (221)
and since IgG crosses the placenta, the IgG antibodies were
considered to be of maternal origin. Data were also available on
first-trimester serum IgG level for ¼th of the women in the study
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Implications
In this first cohort study, we and our collaborators and have
identified, for the first time, an association between T. gondii IgG
serology and self-directed violence at a subsequent time. This
had the largest sample size, and at the time of the study, was
the only study where exposure to T. gondii occurred prior to
self-directed violence. In some meta-analyses, this study had not
been included because it was falsely considered as not measuring
suicide attempts, but non-suicidal self-directed violence only. In
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samples with mixed psychiatric disorders vs. healthy controls
(75, 77), and in a prospective cohort study of Danish women (78).
The association of T. gondii seropositivity with death by suicide
had already been reported in women of post-menopausal age
(72). Trait impulsivity and aggression, intermediate phenotypes
for suicidal behavior (12), were found to be associated with T.
gondii seropositivity in psychiatrically healthy individuals (114).
The context that prompted this new analysis was the implication
of inflammation in suicidal behavior (233). Specifically, levels
of IL-6 and TNF were found to be increased in the plasma
(160), and IL-6 levels were found to be increased in the CSF,
of individuals with a history of suicide attempt relative to nonattempter controls (234). Moreover, individuals who died by
suicide exhibited significant brain microgliosis (235). Likewise,
increased IL-1β, IL-6, and TNF messenger RNA (mRNA) and
protein were found in brain regions previously implicated
histopathologically in suicidal behavior (236).
Several further connections seemed potentially meaningful for
mechanistic considerations. The capacity of the inflammatory
cascade, and specifically of interferon gamma (IFN-γ), to curtail
the infection in immunocompetent individuals (226, 237–239)
is in great part through starvation of T. gondii of tryptophan
(TRP). Additionally, TRP is metabolized into KYN in a reaction
catalyzed by IDO, that is induced by pro-inflammatory stimuli,
and in a reaction catalyzed by tryptophan 2,3-dioxygenase
(TDO), that is induced primarily by glucocorticoids. Kynurenic
acid (KYNA) and QUIN are two important neuroactive
metabolites of the KYN pathway (29). KYNA is an antagonist
at NMDA glutamate receptors while QUIN is excitotoxic, as
it stimulates NMDA receptors. Individuals with schizophrenia
have been demonstrated to have higher seropositivity rates of
T. gondii IgG (54, 61) and also to have elevated levels of KYN
and KYNA in the brain and CSF (240, 241). A first study on
the KYN/TRP system in individuals with suicide attempts found
elevated KYN, but not lower TRP, to be positively associated
with suicide attempt status (29). State dependent elevations of
QUIN have been reported in persons with suicide attempts,
a finding that was robust to adjustment for depression scores
(202). Furthermore, reduced levels of picolinic acid (PIC), and
PIC:QUIN ratio have been reported in suicide attempters (242).
Thus, one key mechanism implicated in the association between
T. gondii and suicidal behavior could be the parasite-induced and
perpetuated low-grade inflammation leading to high QUIN and
increased stimulation of glutamatergic receptors.
KYN and its metabolites could contribute to intermittent
weakening of immune pressure directed on the parasite and
maintaining it in its slow growing form, and potentially result in
reactivation and formation of tachyzoites (fast growing forms).
KYN induces down regulatory apoptosis of effector T cells,
most notably T helper 1 (Th1) cells (228–232), downregulation
of dendritic cell immunogenicity (243), and induction of
regulatory T cell (Treg) differentiation (244) through the
aryl hydrocarbon receptor (AHR), centrally involved in the
generation of Treg (245). By analogy, expression of IDO is
implicated in immune evasion of cancer (246, 247) with a
direct role of KYN in reducing antitumor immune responses via
AHR (248).

fact, the associations with violent suicide attempts were analyzed
and have proven to be the strongest significant associations. We
reported a predictive association between T. gondii IgG antibody
titers soon after delivery and subsequent suicidal behavior. While
approaching closer to causality because of the temporal sequence
of exposure-outcome consistent with our hypothesis, and the
dose-response effect illustrated by the serointensity category
link with suicidal behavior, the study nevertheless is far from
supporting a causal association. For example, it is conceivable
that the results could be alternatively explained by people with
latent or oligosymptomatic psychiatric disturbances with an
increased risk for suicidal behavior having a higher risk of
becoming T. gondii infected prior to mental health diagnosis.
Washing the kitchen knives infrequently after preparation of
raw meat prior to handling another food item, cleaning the
cat litter box, incompletely washed fruits and vegetables, and
consumption of raw or undercooked meat have been specifically
reported to be factors elevating the risk of T. gondii infection
in pregnant women (40, 224). Similarly, endophenotypes for
suicidal behavior, such as impulsivity, represent risk factors for T.
gondii seropositivity as well as future suicidal behavior, and, given
the significant heritability of T. gondii (225), it may be possible
that this increased impulsivity is brought about via genetic factors
for exploratory or self-neglectful behavior. It is important to
note that secondarily adjusting for history of mental illness and
suicidal behavior in the parents (that would potentially reduce
the effect of heritable elements mentioned above) had only a
minor effect on the findings, making it unlikely that the results
are mainly driven by heritable hidden variables related to preexisting subclinical conditions, which would cause rather than be
the consequence of T. gondii infection.

IN SCHIZOPHRENIA: TRYPTOPHAN
DEGRADATION PATHWAY IN
INTERSECTION WITH T. GONDII
SEROLOGY
As a result of a collaboration between T.T. Postolache and D.
Rujescu from the University of Maryland School of Medicine and
Munich University, respectively, as well as other collaborators,
funded by the American Foundation for Suicide Prevention
via a Distinguished Investigator Award, an analysis between
history of suicide attempts and T. gondii serology was published
in 2016 in the Journal of Psychiatric Research (95). As the
kynurenine pathway of tryptophan degradation had been
associated previously with chronic T. gondii infection (226, 227),
history of suicide attempts (29, 202), and immune suppression
(228–232), potentially affecting the capability of T. gondii to
escape immune “pressure,” we investigated the effect of potential
interactions between kynurenine (KYN), kynurenine-tryptophan
ratio (KYN/TRP) and T. gondii serology on suicidal behavior.
By the time of this add-on project we had already reported
the first association of T. gondii serology with suicide attempts
in individuals with mood disorders (74) and then replicated it in
a large sample of individuals with a diagnosis of schizophrenia
(1,000 participants) (76), individuals with mood disorders in
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Methods

affected by parasitic proteins (250). Specifically, in T. gondii
tachyzoite-containing neurons, calcium signaling is impaired
with most of the neurons being hyper-responsive to glutamate;
QUIN, a metabolite of KYN, has additional additive or
synergistic glutamatergic NMDA excitotoxicity. In the context of
intracellular calcium, T. gondii-infected neurons did not return to
normal after stimulation (250), leading to increased KYN (251),
immunosuppression, and reactivation of T. gondii.
It is also conceivable that psychosocial challenges associated
with living with a diagnosis of schizophrenia increase chronic
psychological stress (252), and thus glucocorticoid stimulation
and liver KYN production via TDO, engagement of the
KYN metabolites, and downstream KYN-mediated secondary
immunosuppression, thereby potentially leading to reactivation
of the parasite.
Another possibility is that those with a history of T.
gondii infection, and especially those with high KYN, may
have chronic gastrointestinal inflammation that contributes to
increased risk of suicidal behavior via mechanisms involving
the gut microbiota and increased gut permeability, and
perpetuation of inflammation with intermittent exacerbations, in
particular, considering the schizophrenia diagnostic association
with microbial dysbiosis (253, 254).
The study had several major limitations. The cross-sectional
design invalidates causal inferences and the precedence of
attempts before the blood draw further reduces causal claims.
Additionally, the peripheral, rather than the CSF measurement
of KYN, makes inferences about central interactions rather
speculative. However, KYN freely crosses the blood-brain barrier
in both directions. The study had several strengths: adjustment
for several potential confounders in the statistical models given
the relatively large sample size, the use of SCID in the diagnosis
of schizophrenia, and diagnostic homogeneity by virtue of
including only individuals with schizophrenia. While measuring
CSF metabolites has more validity for mechanisms, measuring
blood biomarkers, such as KYN, in peripheral blood increases the
future possibility of its use in clinical settings.
In summary, it is only when both high KYN and seropositivity
for T. gondii coexist in the same individual that the risk of suicidal
behavior is elevated, in individuals with schizophrenia, at the
very least. Predispositions, triggers, and perpetuating factors may
be the driving forces of this finding. The presence of reciprocal
interactions between KYN and T. gondii is a possibility to be
investigated by future clinical and animal studies.

Nine hundred and fifty participants with a DSM-IV SCID (213)
diagnosis of schizophrenia were recruited from both outpatient
and inpatient settings in Munich. The Positive and Negative
Syndrome Scale for Schizophrenia was used to estimate symptom
severity [PANSS (249)] and antipsychotic medication doses
were expressed as chlorpromazine equivalents. Information
regarding history of suicide attempts was obtained during clinical
interviews conducted at the Department of Psychiatry, Ludwig
Maximillian’s University of Munich, Germany. Statistical analysis
was based on logistic regressions.

Results
Those with KYN in the upper 25th percentile had higher rates
of suicide attempts than those with KYN in the lower 75th
percentile, only in the T. gondii-positive participants, while in
the T. gondii negatives no significant association was identified.
There were no other differences in demographic and clinical
variables between participants with KYN in the upper 25th
percentile and those in the lower 75th percentile in the T. gondiiseropositive patients. In the entire group, KYN top quartile was
not significantly associated with suicide attempts. Similarly, T.
gondii seropositivity was associated with suicide attempt history,
but only in those in the upper quartile for the plasma KYN level,
while in those in the bottom three quartiles, the association was
not significant. No significant association was found between a
history of suicide attempts and plasma KYN as a continuous
variable in the entire sample or T. gondii-based subgroups, or
between a history of suicide attempts and T. gondii serointensity
in the entire sample or KYN-based subgroups.

Relevance
This is the first study that considered two recently uncovered
molecular systems implicated by the Postolache group at the
University of Maryland School of Medicine—in SSDV: T. gondii
serology and the kynurenine pathway in interaction, rather than
separately. Moreover, the finding of an association between
T. gondii and history of suicidal behavior only occurred in
those with high KYN. Similarly, high KYN was related to a
history of suicide attempts only in those with seropositivity to
T. gondii. The mediation, by KYN, of the T. gondii association
(via pro-inflammatory signals in T. gondii positives) is highly
unlikely, because KYN was not significantly associated (either as
a continuous variable or its top quartile) with suicidal behavior in
the entire sample.
The results are consistent with reciprocal interactions between
the KYN pathway and infection. As one possibility, the results
may be consistent with the immunosuppressant effect of
KYN (228–232), potentially contributing to an intermittent
reactivation of T. gondii. Without reactivation, potentially driven
by a dominant vector of immunosuppression, the T. gondii
seropositivity, per se, would not lead to an increased risk of
suicidal behavior.
T. gondii has known effects on the brain that could be
exacerbated by its reactivation and become synergistically
enhanced by downstream neuroactive metabolites of the KYN
pathway. For example, neuronal function could be directly
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T. GONDII, DOPAMINE, AND
ENDOPHENOTYPES OF SUICIDAL
BEHAVIOR
Increases in inflammatory markers have been associated with
behavioral traits that have been proposed as endophenotypes of
suicidal behavior, such as aggressive tendencies and behavior,
anger, hostility, and impulsivity (12, 20, 191, 192, 255), as
reported in animal studies (176–179) as well as human studies
(180, 182–184, 256, 257). Experimental data point toward lowgrade immune activation directly causing aggressive behavior

19

June 2021 | Volume 12 | Article 665682

Postolache et al.

Toxoplasma gondii and Suicidal Behavior

Relevance

(177) rather than representing pure epiphenomena, or nonspecific consequences of stress or arousal.
Though considered harmless in immunocompetent hosts,
“latent” T. gondii infection has been associated with subclinical
personality traits (52, 258–263), as well as with personality
disorders (264). We hypothesized that T. gondii serology is
positively associated with intermediate phenotypes for suicidal
behavior, especially traits such as impulsivity and aggression.
We undertook the study in psychiatrically healthy adults
(114), considering that in psychiatric conditions already linked
with T. gondii seropositivity, associations between impulsivity
and aggression could be, in part, consequences of psychiatric
psychopathology we well as psychiatric treatment.

To our knowledge, using a study design that minimizes
confounding effects of mental illness, trait aggression
and impulsivity had never been studied in relation to
latent Toxoplasmosis.
The sex differences in our findings were not surprising, given
previous sex-specific associations between personality and T.
gondii (258, 260, 261, 263, 276), and may represent expressions
of different vulnerabilities to the parasite, immune changes
in Toxoplasmosis, or propensity for behavioral dysregulation.
However, since, experimentally, sex-specific behaviors (263,
277, 278), secretion of gonadal steroids (279), and sex-specific
neurotransmitter changes (280) occur in rodents infected with
T. gondii, sex-specific effects of the parasite represent a plausible
explanation for the observed association.
These results are consistent with experimental studies. T.
gondii infection increases novelty-seeking in rodents and nonspecifically reduces anxiety-like behaviors (41–45), with the
localization of T. gondii predominantly in brain regions involved
in fear modulation and / or induction, such as the prefrontal
cortex and amygdala (193, 194). Reduced fear- and anxietylike behavior may be the result of dendritic retraction in
the basolateral amygdala (151). In terms of neurotransmitters
underlying the connection between T. gondii impulsivity and
aggression, dopaminergic signaling represents a top candidate
mechanism, as dopamine production was demonstrated to be
elevated with T. gondii infection (281). The genome of T.
gondii has two genes coding for tyrosine hydroxylase (195),
and PC12 cells infected with T. gondii release higher levels
of dopamine in response to stimulation than non-infected
cells (48). Furthermore, in acutely T. gondii-infected rodents,
dopamine metabolism appears somewhat slowed down while
brain dopamine levels are elevated (282, 283). Furthermore, in T.
gondii-infected mice mRNA expression for three genes involved
in dopamine signaling MAO-A, Drd1, and Drd5, encoding
monoamine oxidase A and the D1 and D5 dopamine receptors,
respectively, is decreased (283).
The neurobiology of impulsivity draws heavily from
dopaminergic neurophysiology (284–295). Inconsistencies occur,
with literature suggesting a negative (288, 292, 296–299), as well
as a positive association (300–302). This heterogeneity may be
a result of complexity of neural circuits involved in dopamine
neurotransmission, as well as the topographic specificity of
dopamine receptor subtypes (288, 292, 296–299). Moreover,
genetic polymorphisms in enzymes associated with dopamine
transporter activity, dopamine receptors, and dopamine
metabolic pathways have been associated with impulsivity
(291, 299, 303–305). Furthermore, genetic polymorphisms in
enzymes associated with dopamine receptors and dopamine
transporter activity, as well as dopamine metabolic pathways,
may contribute to heterogeneous associations with impulsivity
(291, 299, 303–305).
Impulsivity in T. gondii infection could be modulated
by dopaminergic neurotransmission altered by the dopamine
producing and altering parasite. MicroRNA-132 is substantially
upregulated by all three-prototype T. gondii strains (283).
Moreover, in the same study, upregulation of microRNA-132 was

Methods
IgG antibody seropositivity for T. gondii was analyzed in
relationship to traits of impulsivity and aggression. For evaluating
T. gondii specificity, two other latent neurotropic infections,
cytomegalovirus (CMV) and herpes simplex virus 1 (HSV1)
were also analyzed. The sample included 1,000 residents of the
Munich metropolitan area [490 women, 510 men, mean age
(SD): 53.6 (15.8)] with no Axis I or II conditions by SCID for
DSM-IV. Trait impulsivity (Sensation-Seeking Scale-V [SSS-V])
and aggression scores were obtained from a German version of
the Buss-Durkee Hostility Questionnaire, The Questionnaire for
Measuring Factors of Aggression (FAF-Fragebogen zur Erfassung
von Aggressivitätsfaktoren) (265, 266): FAF is composed of 76
items, of which 66 explore five components of aggressive behavior
including FAF-Self-Aggression (11 items), FAF-Total Aggression
(35 items) and its three component subscales: FAF-Spontaneous
Aggression (19 items); FAF-Reactive Aggression (13 items); FAFIrritability (13 items). Internal consistency of FAF was good as
indicated by Cronbach’s alpha values ranging from 0.61 to 0.79,
and test-retest reliability was good as well (265).
The Disinhibition [SSS-V (DIS)] subscale of the Sensation
Seeking Scale-V was used to measure impulsive sensationseeking (267). The SSS-V was developed to evaluate differences in
individuals’ needs for stimulation and arousal (268, 269). Of the
four SSS-V subscales, impulsive sensation was shown to have the
strongest association with reckless behavior (270–272) and risky
driving (273). The SSS-V (DIS) subscale scores have previously
been used to predict repeated suicide attempts (274) and higher
aggression (275), but mainly as a primary measure of impulsivity
and to calculate an “impulsivity score.”

Results
T. gondii seropositivity was associated with higher impulsive
sensation-seeking (SSS-V Disinhibition) only among younger
men (p < 0.01) aged 20–59 years old (median age = 60 years)
(see Figure 5).
Higher trait reactive aggression scores were associated with
T. gondii IgG seropositivity in women only (see Figure 6). All
associations with the other latent pathogens HSV1 and CMV
were not significant, and adjustment for their serology did not
reduce the significant T. gondii findings.
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FIGURE 6 | Trait Reactive Aggression (FAF) by Age, Sex, and T. gondii IgG Status (N = 949). Women, but not men, had a significant (p < 0.01) association between
T. gondii IgG seropositivity and higher trait reactive aggression scores (determined by the FAF-Fragebogen zur Erfassung von Aggressivitätsfaktoren). T. gondii IgG (–),
T. gondii IgG seronegative, T. gondii IgG+, T. gondii IgG seropositive. The two age groups are separated by median age (60 years). The overall reactive aggression
scores are higher in men, but T. gondii-positive women have a similar level of reactive aggression with men. [Reprinted with permission from (114); Copyright (2015);
with permission from Elsevier; License # 4964160181012].

found to be associated with decreasing the metabolizing enzyme
(i.e., monoamine oxidase A), changes in dopamine receptor
signaling, and decreasing expression of D1-like dopamine
receptors, a dopamine receptor involved in the negative feedback
regulation of dopamine release in the brain (306), resulting
in higher levels of dopamine. Indeed, in striatal tissue of
mice infected with T. gondii, dopamine levels are elevated by
38% and microRNA-132 is upregulated (283). Additionally,
elevated levels of homovanillic acid, a dopamine metabolite,
and increased synthesis of dopamine have been found in
dopaminergic neurons infected with T. gondii (48, 281, 307).
As a higher acoustic startle response magnitude has been
associated with increased dopamine production (308, 309), an
increased startle response among T. gondii-infected participants
(310) has been attributed to increased dopamine production
in T. gondii positives. The prevention of T. gondii-induced
behavioral alterations in animals with anti-dopaminergic agents
further supports a T. gondii–dopamine connection (311, 312).
Consistently, dopamine D2-receptor agonists reduce response
impulsivity in humans (292) and, experimentally, in rodents
(288). Conversely, premature responding in highly impulsive rats
is enhanced by administration of the dopamine D2/D3 receptor
antagonist nafadotride into the accumbens shell in rats (313).
Moreover, low dopamine D2-like receptor mRNA expression in
the mesolimbic pathway was identified in highly impulsive rats
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(314). Additionally, a greater response impulsivity in a motor
impulsivity animal model is manifested in rats that have lower
dopamine D2/D3 receptor availability in the nucleus accumbens
(285). In human participants, inhibition-related functional
magnetic resonance imaging (fMRI) activation in frontostriatal
circuitry positively correlates with dopamine D2/D3 receptor
availability and negatively correlates with impulsivity (315).
Additionally, a negative association with levels of impulsive
aggression have been reported with CSF levels of homovanillic
acid, the main metabolite of dopamine (316). There are findings
that suggest a positive, rather than a negative, association
between dopaminergic function and impulsivity (300–302). Yet,
all studies support a robust effect of dopaminergic modulation
of impulsivity and suggest that T. gondii, through cellular and
biochemical correlates consisting of reductions in neuronal spine
density and dopamine levels, as demonstrated in the nucleus
accumbens core (317), can modify impulsivity—a major risk
factor and intermediate phenotype of suicidal behavior.
Variations in gonadal steroid levels associated with T.
gondii infection in humans, implicated in aggression and selfdirected violence, may contribute to our reported sex and
age differences (283, 318–322). An indirect support for the
hormonal mechanism of sex-age group differences is that FAFSelf-Aggression scores among T. gondii-positive women switches
from lower to higher around the average menopause age of
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FIGURE 7 | Composite Impulsivity and Aggression (age as covariate) in T. gondii seronegative (–) and seropositive (+) participants with history of Intermittent Explosive
Disorder. Impulsivity (aggression) refers to Composite Impulsivity scores with Composite Aggression scores as a covariate; aggression (impulsivity) refers to Composite
Aggression scores with Composite Impulsivity scores as a covariate. NS, not significant; *p ≤ 0.05. Significantly elevated Aggression and Impulsivity scores in T. gondii
positives. Reciprocally adjusting impulsivity and aggression for each other yields a significant association with T. gondii only for Aggression [Reprinted with permission
from (117); Copyright 2016, Physicians Postgraduate Press. Reprinted by permission].

we were able to replicate the association between T. gondii
and impulsivity/aggression traits in a clinical population with
extreme impulsive-aggression, specifically Intermittent Explosive
Disorder (IED) (117)—(see Figures 7, 8).

German women (323, 324). Animal studies also support potential
sex differences comparing monoamine neurotransmission in
male vs. female rats in acute and chronic infection demonstrating
sex-differences (280). Gonadal steroids are increased in T. gondiiinfected rats, but not mice, and play a role in behavioral changes
induced by chronic Toxoplasmosis in male rats (278, 279),
but not female rats. In humans associations between suicidal
behavior and blood levels of gonadal steroids have been reported
in both women (324) and men (325–327).
In addition to being a cross-sectional study, there were
limitations worth acknowledging. No history of actual episodes
of impulsive behavior or aggression were acquired. No direct
objective measures of behavioral aggression or impulsivity were
obtained and neuropsychological testing of impulsivity did not
take place. Moreover, aggressive and impulsive traits could
modify the likelihood of exposure to T. gondii and, thus,
of T. gondii infection. There may be residual confounding
by unmeasured socioeconomic factors, as the proxy use of
educational attainment could be of only limited value. Finally,
including only healthy individuals (actually super healthy—given
exclusion of those with family history of mental illness) limits
the generalizability of the study. Yet, we believe that lower
generalizability is a fair price to pay, considering the uncovering
of personality traits linked with T. gondii in a sex- and age-specific
fashion, even when the confounding of underlying mental
illness and substance abuse is eliminated by design. Moreover,
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ENDOPHENOTYPES OF SUICIDAL
BEHAVIOR (IMPULSIVITY, AGGRESSION)
AND T. GONDII SEROLOGY—THE
MODERATING ROLE OF AGE, GENDER,
AND PLASMA
PHENYLALANINE:TYROSINE RATIO
This project (115) representing a follow-up on a previous study
(114) that uncovered that T. gondii seropositivity is positively
associated with impulsive sensation seeking in younger men. The
study was based on the concepts that impulsivity is regulated
by dopaminergic and serotonergic signaling, and, because T.
gondii is known to directly affect dopaminergic signaling and
tryptophan degradation pathways via immune activation, blood
levels of precursors of serotonin and dopamine may change
the association between T. gondii and impulsivity, and thus
risk of suicide. In addition to dopamine, serotonin is another
key neurotransmitter involved in impulsivity regulation and
dysregulation (328–331). Activation of the KYN pathway of
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FIGURE 8 | State and Trait Anxiety, Anger, and Depression (z) scores (age as covariate) in T. gondii seronegative (–) and seropositive (+) participants. z scores were
†
used to place all symptom measures on the same scale. NS, not significant; p < 0.10; *p ≤ 0.05. While State and Trait Anxiety and Depression were not significantly
different between T. gondii-positive and T. gondii-negative participants with Intermittent Explosive Disorder, the State and Trait Anger is significantly higher in T.
gondii-positive participants relative to T. gondii-negative participants [Reprinted with permission from (117); Copyright 2016, Physicians Postgraduate Press.
Reprinted by permission].

TRP metabolism, leading to diversion of TRP from production
of serotonin (226), results in reduced serotonin production
and an elevation of impulsivity and impulsive aggression—
intermediate phenotypes of suicidal behavior. Measures of
serotonin, norepinephrine, and dopamine have been found to be
altered in suicide brains (332).
The first step in the synthesis of dopamine is the conversion
of the amino acid Phe to Tyr, catalyzed by the enzyme Phe
hydroxylase (PAH). It is followed by a two-step process, with
Tyr being converted into dopamine via Tyr hydroxylase (the
rate-limiting enzyme in catecholamine biosynthesis) and Ltype amino acid decarboxylase (333, 334). The Phe:Tyr ratio
is an inverse estimate of PAH activity (335), and is higher
in pro-inflammatory conditions, including trauma and sepsis
(336), human immunodeficiency virus infection (337), cancer
(338), as well as psychiatric conditions such as depression (339,
340) and schizophrenia (341–343). The Th1 immunity leads to
depletion of (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin (BH4),
an essential cofactor of PAH (335, 344). Thus, the dysfunction of
PAH results in a high Phe:Tyr ratio (340, 345), as a consequence
of Th1 activation (335, 344), which, in turn, has been presented
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above as an important mechanism (346) to keep T. gondii in
check by applying immune pressure to prevent its reactivation.
This could lead to a causal association between T. gondii infection
and high Phe:Tyr ratio. At the same time, the dopaminergic
alterations potentially induced by T. gondii may be compounded
by the low availability of Tyr through inflammation-induced
PAH dysfunction.

Methods
In 950 psychiatrically healthy participants as described above and
in Cook et al. (114), T. gondii IgG seropositivity was related
to trait impulsivity scores (calculated as explained in detail in
different reports) (114, 115) in interaction with categorized levels
(top 25% vs. bottom 75%) of Phe, Tyr, Kyn, and Trp measured by
high performance liquid chromatography (HPLC), as described
elsewhere (343, 347). Phe:Tyr ratio and the Kyn:Trp ratio
were calculated, and age and gender were used for adjustment
in analysis of covariance (ANCOVA) with impulsivity scores
as a dependent variable. Participants were stratified into two
categories based on their age (i.e., older and younger), based on a
median split (60 years old).
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FIGURE 9 | Endophenotypes for suicidal behavior. Comparisons of impulsivity scores between T. gondii IgG-seronegative vs. T. gondii IgG-seropositive individuals
and high vs. low phenylalanine/ tyrosine ratio (Phe:Tyr) stratified by gender and groups. Scoring significantly higher on impulsivity scores than other groups required
four coexistent criteria, i.e., for a participant to be male, young, T. gondii-positive, and in the upper quartile of Phe:Tyr. Impulsivity scores in seronegative vs.
seropositive participants stratified by Phe:Tyr categories, gender, and age. Disinhibition subscale of the Sensation Seeking Scale-V [SSS-V (DIS)] was used to obtain
impulsivity scores, which are represented as standard errors (SEs) and least square means (adjusted for age in the age category and stratified by categorical variable).
The following strata were included: older women (aged ≥ 60 years), older men (aged ≥ 60 years), younger women (aged 20–59 years), and younger men (aged 20–59
years). If the Phe:Tyr ratio was in the lower 75th percentile, it was considered LOW and if the ratio was in top 25th percentile, it was considered HIGH. Statistically
significant interactions were uncovered between T. gondii seropositivity, gender, age category, and Phe:Tyr ratio upon performing ANCOVA analysis of impulsivity
(Continued)
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FIGURE 9 | scores [F (1, 896) = 7.772, p = 0.007]. A significant interaction between Phe:Tyr ratio and T. gondii seropositivity status was present in younger men
[F (1, 173) = 10.635, p = 0.001], but it was not significant in other strata {i.e., older women [F (1, 84) = 1.868, p = 0.173), younger women [F (1, 280) = 0.516, p = 0.473],
older men [F (1, 256) = 0.593, p = 0.442]}. *Upon performing Tukey’s Honestly Significant Difference Test, the impulsivity scores were significantly higher in younger men
who had HIGH Phe:Tyr ratios and were also T. gondii-seropositive, as compared to all other subgroups (p < 0.01 for all). Additional significant differences within the
subgroups were not present [Reprinted with permission from (115); Copyright (2018); with permission from Elsevier; License # 4964311353323].

Results

limit the increased risk of suicidal behavior due to elevated
impulsivity in this specific group. Thus, simply restoring Tyr
(widely available as a nutritional supplement and relatively safe)
instead of a more complicated and potentially risky intervention,
i.e., “sterilizing” T. gondii and thus preventing a chronic latent
infection, may achieve a desired level of therapeutic benefit, and
deserves testing in small and, ultimately, larger clinical trials.

An interaction was identified between seropositivity status for T.
gondii and Phe:Tyr ratio category [F (1, 173) = 10.635, p = 0.001]
that was statistically significant only in younger men. A post hoc
Tukey’s Honestly-Significant-Difference test indicated that only
in younger men (aged 20 to 59 years), who also had high Phe:Tyr
ratios (i.e., ratios that fell into the top quartile), were statistically
significant differences in the impulsivity scores between T.
gondii seropositive and seronegative individuals identified. In all
other groups, there were no statistically significant findings (see
Figure 9).
Phe:Tyr could be just a marker of severity through immuneactivation responses, and that may explain why the Phe:Tyr ratio
alone does not significantly associate with impulsivity (the ratio
is not a mediator, only a marker of severity) and why the T.
gondii serology alone does not relate to impulsivity (only a more
severe infection—extensive, virulent, and neurotropic, leading
to a stronger immune response—would be sufficient to induce
higher impulsivity).
Furthermore, somewhat arguing against an immune
hypothesis, in another study on impulsivity and aggression
in a clinical population (i.e., individuals with IED), IL-6 did
not appear to mediate our uncovered significant association
between IED diagnosis/ trait impulsivity in IED and T. gondii
seropositivity (117). However, we cannot rule out the role of
other cytokines not analyzed in that study, including IFN-γ
and TNF, which could specifically induce PAH and act to
restrain T. gondii (226, 237–239). It is also possible that changes
in IL-6 levels are not seen in peripheral blood circulation
as the pro-inflammatory processes keeping T. gondii from
reactivation are limited to the CNS. The possibility of alternate
genetic, developmental, clinical, and environmental enzymatic
predispositions toward inhibition of PAH activity in response to
pro-inflammatory stimuli cannot be ruled out. Furthermore, it
is possible that lower norepinephrine synthesis, in the context
of reduced Tyr (see Figure 10) and infection, may lead to
increased hopelessness, and then additionally, contribute to
a reduced immune-modulatory activity of the noradrenergic
system (see Figure 11). Indeed, several studies have implicated
the noradrenergic system in suicidal behavior (332, 348, 349).

HOPELESSNESS AND T. GONDII
SEROINTENSITY IN OLD ORDER AMISH
An association between chronic infection with T. gondii and
depression has been reported in various study populations, such
as pregnant women (66), psychiatric patients (67), and women
Veterans (34); although this association has not been confirmed
in other studies (53, 68–71). Inconsistencies in these findings
could potentially be a result of heterogeneity in the study samples,
which may include distinct associations between individual
symptoms of depression and chronic Toxoplasmosis, co-morbid
substance use disorders, or lifestyle variations among study
subjects. To minimize these confounding effects, the Postolache
team at the University of Maryland conducted a cross-sectional
study in the Old Order Amish (OOA) of Lancaster, Pennsylvania
(155), who, as compared to the general US population, have
comparatively higher prevalence of T. gondii infection, lower
substance use prevalence, and are rather homogeneous in terms
of cultural practices, socioeconomic status and lifestyles (40,
350, 351). In this study, potential associations between T. gondii
IgG serology and two predominant state markers for suicidal
behavior, both translatable to animal models (anhedonia and
dysphoria/hopelessness), were explored.

Methods
Details about the study methods are described elsewhere (155).
In summary, the study sample included OOA (N = 306)
[mean age = 46.1 ± 16.7 years; 62.4% women]. Patient
Health Questionnaires (PHQ-2 and PHQ-9) were used to
ascertain cardinal symptoms of depression (anhedonia and
dysphoria/hopelessness) and ELISA was used to measure T.
gondii IgG titers. Multivariable linear methods were used to
analyze the relationship between T. gondii IgG antibodies
(serointensity and seropositivity) and various combinations
of time-dependent cardinal symptoms of depression (i.e.,
current/past/ever dysphoria/hopelessness and anhedonia scores),
while adjusting for gender and age. Participants were described
as having “current” symptoms of depression if they experienced
these symptoms in the last month.

Relevance
Treatment trials focused on reducing the elevated risk of suicide
attempt in individuals seropositive for T. gondii could focus on
impulsivity as a mediator, and, for that purpose, the study could
specifically only include younger seropositive males with elevated
Phe:Tyr ratios. Second, if the insufficient tyrosine availability
combined with an increase in dopamine secretion in young T.
gondii-seropositive males could have a mediating role, elevating
Tyr levels in those with high Phe:Tyr ratios could, potentially,
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FIGURE 10 | Graphic illustration of norepinephrine (NE) synthesis in the brain of a rodent. Synthesis of NE occurs from tyrosine through the following steps: (a)
tyrosine hydroxylase converts tyrosine to levodopa or l-3,4-dihydroxyphenylalanine (L-DOPA); (b) L-type amino acid decarboxylase converts L-DOPA to dopamine; (c)
vesicular monoamine transporter (VMAT) transports dopamine into the presynaptic vesicles; and (d) dopamine-β-hydroxylase (DBH) converts dopamine into NE. NE
binding to β- and α- adrenergic receptors takes place after its release from the presynaptic vesicles into the synapse, from where norepinephrine transporter (NET)
mediates its reuptake. Locus coeruleus (LC) houses the majority of brainstem noradrenergic neurons and it projects to several regions in the brain, including the
amygdala, hippocampus and medial prefrontal cortex (MPC) [Reprinted from (363); Copyright (2020); with permission from Elsevier; License # 4986231317003].

Results

trait hopelessness has shown a stronger risk with suicidal
behavior than state hopelessness (357). Our study generates the
new hypothesis that chronic T. gondii infection may elevate
risk of suicide via increasing propensity to trait hopelessness, a
hypothesis that warrants further research.
The association with serointensity, rather than with
seropositivity, may suggest that it is not the infection per
se, but its extent, virulence, and recency that are predictively
linked with hopelessness, and thus an increased suicide risk.
At the molecular level, T. gondii infection-induced siphoning
of tryptophan (a precursor for serotonin) (358) toward the
kynurenine pathway, instead of the serotonin pathway (227),
could explain the associations that we had uncovered in this
study. IFN-γ is released as a response to T. gondii infection,
which in turn upregulates IDO—the rate-limiting enzyme that
directs the metabolism of tryptophan to kynurenine metabolites
in the brain (359). This molecular shift is supposed to be
protective for the host, as it leads to a relative deficiency of
tryptophan, an amino acid that is essential for T. gondii’s growth
(227). However, it leads to the production of more kynurenine
and other metabolites of the kynurenine pathway, and results
in a relative deficiency of serotonin in the brain—well-known
to be associated with depression (360). Moreover, higher CSF
levels of QUIN (metabolite of kynurenine pathway) (202, 242)
and plasma levels of KYN itself (29) have been reported to
be associated with a history of suicide attempts in individuals
with depressive disorders (361). Additionally, chronic T. gondii
infection may inhibit noradrenergic signaling, which, in addition
to contributing directly to alterations in mood states, may also

T. gondii IgG serointensity had a significant positive association
with current combined anhedonia and dysphoria/hopelessness
[OR = 1.34 (95% CI: 1.01–1.79); p = 0.043], as well as
current dysphoria/hopelessness [OR = 1.26 (95% CI: 1.01–
1.58); p = 0.045]. However, the association between T. gondii
serointensity and current anhedonia (in isolation) was not
significant. The relationships between T. gondii serointensity
and current predominant anhedonia and dysphoria were
also non-significant when either (but not both) of them
were present in the study subjects in the past month (i.e.,
current dysphoria/hopelessness or anhedonia). Additionally,
significance was not reached when associations between T.
gondii serointensity and past/ever mood phenotypes were
analyzed. With regards to T. gondii seropositivity, its association
with current combined dysphoria/hopelessness and anhedonia
[OR = 2.99 (95% CI: 0.97–9.15); p = 0.056] and current
dysphoria/hopelessness [OR = 2.31 (95% CI: 0.97–5.50); p =
0.058] revealed a statistical trend/low-grade significance.

Relevance
These results point toward associations between T. gondii
IgG serointensity and dysphoria/hopelessness. In patients with
depression, dysphoria/hopelessness is an accepted risk factor for
suicide (352, 353). Trait- and state-related hopelessness have both
been reported to be present in an equivalent quantifiable degree
in patients with depressive disorders (354). Trait hopelessness
has been specifically linked to personality traits, including low
Extraversion (355) and high Neuroticism (354, 356). Notably,
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FIGURE 11 | Schematic illustrating the regulation of inflammatory response by noradrenergic neurotransmission during an infection in the rodent brain. (A)
Norepinephrine (NE, green triangles) is released from locus coeruleus noradrenergic neurons that are functioning normally. NE binds to adrenergic receptors located
on immune cells, astrocytes, neurons, and microglia. Microglia and GABAergic neurons are activated by NE, cells that help with downregulation of pro-inflammatory
cytokines and neuronal dendrite repair. (B) In rodents, neurons have been reported to undergo several changes in response to chronic T. gondii infection, including
severe reduction in NE and dopamine-β-hydroxylase (DBH), within noradrenergic neurons, redistribution of GAD67 (an enzyme involved in GABA synthesis), and loss
of dendritic spines. Additionally, reduced glutamate transporter Glt-1 has been observed in astrocytes of rodents chronically infected with T. gondii. Elevation in the
levels of inflammatory cytokines, including interleukin (IL)-1β, tumor necrosis factor (TNF) and interferon (IFN)-γ also occurs. The model from Laing et al. states that
since noradrenergic signaling is suppressed during chronic T. gondii infection, the brakes on inflammation are lifted leading to increased cytokine concentrations. The
behavioral alterations seen in rodents chronically infected with T. gondii could be partly explained by these changes. (C) Laing et al. suggest that the elevated
pro-inflammatory cytokines can be suppressed and the lack of NE can be compensated for (at least partially) by treating the T. gondii-infected rodents with
Guanabenz (a noradrenergic agonist), which has been linked with reversal of T. gondii infection-induced hyperlocomotion in rodents) [Reprinted from (363); Copyright
(2020); with permission from Elsevier; License # 4986231317003].

much greater T. gondii seroprevalence in the OOA than in the
US population (40, 350), allowing us to conduct multivariable
analyses, and less heterogeneity (occupation, meal preparation,
food consumption, hygienic practices, and social supports, as
well as very limited use of tobacco, alcohol, and other substances)
(350, 351).
Long-term future longitudinal and interventional studies
on individuals who have report dysphoria/hopelessness
(with/without anhedonia) potentially related to a chronic

lead to a lower tonic inhibition of excessive neuroinflammation
(see Figure 11), ultimately resulting in neuronal damage, changes
in brain connectivity and cognitive deficits, thus contributing to
the risk for suicidal behavior (122, 362, 363).
Some of the limitations of this study include a crosssectional design, not using standardized structured instruments
and collateral information to diagnose depression, and
potential underreporting of symptoms of depression due to
reporting/recall bias or cultural factors. The strengths included a

Frontiers in Psychiatry | www.frontiersin.org

27

June 2021 | Volume 12 | Article 665682

Postolache et al.

Toxoplasma gondii and Suicidal Behavior

infection with T. gondii could test the might from certain
targeted approaches to treatment involving psychotherapeutic
and pharmacological interventions. In depressed patients,
cognitive behavioral therapy has shown promising results
in reducing dysphoria/hopelessness (364, 365). Additionally,
anti-inflammatory interventions for seropositive individuals
who have increased inflammatory markers in their blood, as
advocated recently (366–368), primary prevention strategies
to reduce targeted gender-specific risk factors for infection
(40), and anti-parasitic medications in those with evidence
of high frequency of parasite reactivation with temporally
adjacent exacerbation of cardinal depression symptoms, could
all help mitigate a possible mediator role of the T. gondii-suicide
connection—i.e., dysphoria/hopelessness.

of bio, psycho, socio, cultural and economic nature) may
have impactful moderating effects; and (c) causality has not
been demonstrated; “hidden variables” and reverse causality
are possible. Future interventional randomized studies will be
necessary to confirm our causal inferences, and, if so, to seek
to establish in suicidology, a first etiology-based treatment, and
hopefully, primary prevention.
Theoretically, while the increased risk of suicide with T.
gondii infection fits well into the theories of Stress-diathesis
(9–12) and interpersonal theory of suicidal behavior (13),
addressing chronic Toxoplasmosis to reduce the risk of suicide
coherently aligns with the Social-Ecological Framework of
Suicide Prevention (369). This framework is grounded in
the Centers for Disease Control and Prevention framework
for addressing health issues. Adopting a multi-level public
health approach, Cramer and Kapusta (369), assert that suicide
risk is associated with societal (e.g., poverty), community
(e.g., barriers to health care access), relational (e.g., social
isolation), and individual (e.g., chronic condition) influences.
Conceptualizing suicide risk in this manner allows for
multi-level interventions. Specifically, T. gondii, low-grade
inflammation, and downstream molecular changes (e.g.,
low tyrosine and tryptophan, high kynurenine pathway
metabolites) can be addressed at the level of socioeconomical
predispositions (poverty and poor hygiene contributes to high
seroprevalence), as preventative targets (e.g., food preparation
and general hygiene) or as targetable biological mediators
or moderators. This may ultimately contribute to a reduced
burden of suicidal behavior and untimely mortality. In sum, our
findings substantiate the need for longitudinal studies based on
infection (seroconversion) and reactivation with monitoring of
subsequent impulsivity, aggression, hopelessness/dysphoria,
deficits in decisions making, and in the long run,
randomized interventional experimental, preventative and risk
lowering paradigms.

OVERALL IMPLICATIONS, LIMITATIONS,
AND CONCLUSION
Three meta-analyses confirmed our initial reported associations
between T. gondii and suicidal behavior. Furthermore,
serointensity-response associations, linked with endophenotypes
of suicidal behavior, and PAF analyses, suggest a potential
sizable benefit of (1) preventing T. gondii infection; (2) treating
the infection once it has occurred; or (3) intervening on
molecular systems that interact with the parasite and may
contribute to suicide risk. Together, these strategies have
the potential to mitigate the potential pro-suicidal effect of
T. gondii infection. Candidate molecular moderators may
include elevated plasma kynurenine for pro-suicidal effects of
T. gondii in schizophrenia and high plasma Phe:Tyr ratio for
impulsivity-elevating effects of T. gondii in young males with no
psychiatric history.
Our review, as well as the field in general, have substantial
limitations. The limitations of our current review include
its non-systematic nature and the presentation of results of
different studies in the way it was reported originally in
each study, rather than integrating it. Even for the results
of the three meta-analyses, we allowed original differences
to be apparent, rather than homogenizing or meta-analyzing
the three studies. We thought that three independent metaanalyses that were concordant in confirming the T. gondii–
suicidal behavior associations, despite differences in approach
and especially study selection, represent stronger arguments to
validate our initial observations, rather than a synthesized macroanalysis by our team, which would be certainly not immune to
self–confirmatory bias. Limitations of this field include: (a) the
absence of a clear documentation of T. gondii CNS localization
in chronic Toxoplasmosis in immunocompetent humans [our
team is currently completing such a report using high resolution
structural MRI associations with IgG anti T. gondii oocyst, i.e.,
infection occurring directly through oocyst, rather than tissue
cyst (manuscript in preparation)]; (b) in contrast to European
countries (72), a lack of a correlation between national suicide
rates and T. gondii seropositivity worldwide. These suggest that
interactive factors related to T. gondii (serotype, transmission
modality) and host (genetics, suicide risk and protective factors
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self-directed violence; NMDA, N-methyl-D-aspartate; NOS,
Newcastle and Ottawa statements; OOA, Old Order Amish;
OR odds ratio; PAF, population attributable fraction; PAH,
phenylalanine hydroxylase; PANSS, Positive and Negative
Syndrome Scale for Schizophrenia; Pglob, global preference;
PHQ-2, Patient Health Questionnaire-2; PHQ-9, Patient Health
Questionnaire-9; PIC, picolinic acid; PRISMA, Preferred
Reporting Items for Systematic Reviews and Meta-Analyses;
PROSPERO, The International Prospective Register of
Systematic Reviews; QUIN, quinolinic acid; RR, risk ratio;
SCID, Structured Clinical Interview for DSM Disorders;
sgACC, subgenual anterior cingulate cortex; SSDV, suicidal
self-directed violence; SSS-V, Sensation-Seeking Scale-V; SSS-V
(DIS), Disinhibition subscale of the Sensation Seeking Scale-V;
STROBE, Strengthening the Reporting of Observational Studies
in Epidemiology; TBI, traumatic brain injury; TDO, tryptophan
2,3-dioxygenase; T. gondii, Toxoplasma gondii; Th1, T helper
1; TNF, tumor necrosis factor; Treg, regulatory T cell; TRP,
tryptophan; US, United States; USA, United Stated of America;
VMAT, vesicular monoamine transporter.

AHR, aryl hydrocarbon receptor; ANCOVA, analysis of
covariance; BH4, (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin;
CI, confidence interval; CMV, cytomegalovirus; CNS, central
nervous system; CSF, cerebrospinal fluid; DALY, disabilityadjusted life years; DSM-IV, Diagnostic and Statistical Manual
of Mental Disorders, fourth edition; ELISA, enzyme-linked
immunosorbent assay; FAF, The Questionnaire for Measuring
Factors of Aggression (FAF-Fragebogen zur Erfassung von
Aggressivitätsfaktoren); fMRI, functional magnetic resonance
imaging; HPLC, high performance liquid chromatography;
HSV1, herpes simplex virus 1; IBD, inflammatory bowel disease;
IDO, indoleamine 2,3-dioxygenase; IED, Intermittent Explosive
Disorder; IFN-γ, interferon gamma; IgG, immunoglobulin
G; IgM, immunoglobulin M; IL, interleukin; ISI, Institute for
Scientific Information; KYN, kynurenine; KYNA, kynurenic acid;
LC, locus coeruleus; L-DOPA, l-3,4-dihydroxyphenylalanine;
MCC, midcingulate cortex; NF-SSDV, non-fatal suicidal
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